| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | SLC24A5 SLC37A1 SLC25A24 CACNA1S SLC9A8 ATP6V0B ABCB7 SLC52A1 SLC4A8 SLC37A3 SLC39A9 SLC39A11 SLC25A33 SLC6A17 ABCB5 SLC25A14 SLC22A11 ATG2B TTYH2 SLC38A5 ATG2A SLC44A4 SLC22A24 SLC1A7 SLC2A3 RYR2 RHD RYR3 ABCB1 ABCB4 CACNG3 CACNG2 SLC30A7 SLC38A1 SLC38A2 SLC22A9 SLC35A3 CACNG8 CACNG7 SLC16A5 SLC16A4 SLC16A3 SLC25A40 SLC12A9 SLC50A1 SLC16A2 P2RX2 KCNH1 SLC16A14 SLC22A2 SLC28A1 PITPNM3 SLC9A7 CACNG4 CTNS SLC23A2 SLC29A1 ABCG8 SLC35B1 SLC22A31 | 4.06e-29 | 1289 | 169 | 60 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC24A5 SLC37A1 SLC25A24 CACNA1S SLC9A8 ATP6V0B ABCB7 SLC52A1 SLC4A8 SLC37A3 SLC39A9 SLC39A11 SLC25A33 SLC6A17 ABCB5 SLC25A14 SLC22A11 TTYH2 SLC38A5 SLC44A4 SLC22A24 SLC1A7 SLC2A3 RYR2 RHD RYR3 ABCB1 ABCB4 CACNG3 CACNG2 SLC30A7 SLC38A1 SLC38A2 SLC22A9 SLC35A3 CACNG8 CACNG7 SLC16A5 SLC16A4 SLC16A3 SLC25A40 SLC12A9 SLC50A1 SLC16A2 P2RX2 KCNH1 SLC16A14 SLC22A2 SLC28A1 SLC9A7 CACNG4 CTNS SLC23A2 SLC29A1 ABCG8 SLC35B1 SLC22A31 | 2.31e-28 | 1180 | 169 | 57 | GO:0022857 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC24A5 SLC37A1 SLC25A24 SLC9A8 ATP6V0B ABCB7 SLC4A8 SLC37A3 SLC6A17 ABCB5 SLC25A14 SLC22A11 SLC38A5 SLC44A4 SLC1A7 ABCB1 ABCB4 SLC38A1 SLC38A2 SLC22A9 SLC35A3 SLC16A5 SLC16A4 SLC16A3 SLC12A9 SLC16A2 SLC16A14 SLC22A2 SLC28A1 SLC9A7 CTNS SLC23A2 SLC29A1 ABCG8 SLC35B1 | 5.49e-23 | 477 | 169 | 35 | GO:0022804 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC24A5 SLC37A1 SLC25A24 SLC9A8 SLC4A8 SLC37A3 SLC6A17 SLC25A14 SLC22A11 SLC38A5 SLC44A4 SLC1A7 SLC38A1 SLC38A2 SLC22A9 SLC35A3 SLC16A5 SLC16A4 SLC16A3 SLC12A9 SLC16A2 SLC16A14 SLC28A1 SLC9A7 CTNS SLC23A2 SLC29A1 SLC35B1 | 1.94e-21 | 296 | 169 | 28 | GO:0015291 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC37A1 SLC25A24 SLC52A1 SLC4A8 SLC37A3 SLC22A11 SLC38A5 SLC44A4 SLC1A7 SLC2A3 ABCB1 SLC38A1 SLC38A2 SLC22A9 SLC35A3 SLC16A5 SLC16A4 SLC16A3 SLC25A40 SLC16A2 SLC16A14 SLC22A2 CTNS SLC23A2 SLC35B1 | 3.91e-18 | 293 | 169 | 25 | GO:0008514 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC24A5 SLC37A1 SLC25A24 CACNA1S SLC9A8 ATP6V0B SLC4A8 SLC37A3 SLC39A9 SLC39A11 SLC25A14 SLC22A11 TTYH2 SLC38A5 SLC1A7 RYR2 RHD RYR3 CACNG3 CACNG2 SLC30A7 SLC38A1 SLC38A2 CACNG8 CACNG7 SLC16A3 SLC12A9 KCNH1 SLC28A1 SLC9A7 CACNG4 CTNS SLC23A2 SLC29A1 | 1.01e-15 | 758 | 169 | 34 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC24A5 CACNA1S SLC9A8 ATP6V0B SLC4A8 SLC39A9 SLC39A11 SLC25A14 SLC38A5 SLC1A7 RYR2 RHD RYR3 CACNG3 CACNG2 SLC30A7 SLC38A1 SLC38A2 CACNG8 CACNG7 SLC16A3 SLC12A9 KCNH1 SLC28A1 SLC9A7 CACNG4 CTNS SLC23A2 SLC29A1 | 7.92e-14 | 627 | 169 | 29 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC24A5 CACNA1S SLC9A8 ATP6V0B SLC4A8 SLC39A9 SLC39A11 SLC25A14 SLC38A5 SLC1A7 RYR2 RYR3 CACNG3 CACNG2 SLC30A7 SLC38A1 SLC38A2 CACNG8 CACNG7 SLC16A3 SLC12A9 P2RX2 KCNH1 SLC28A1 SLC9A7 CACNG4 CTNS SLC23A2 SLC29A1 | 3.35e-13 | 664 | 169 | 29 | GO:0008324 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC24A5 CACNA1S SLC9A8 SLC4A8 SLC39A9 SLC39A11 SLC38A5 SLC1A7 RYR2 RYR3 CACNG3 CACNG2 SLC30A7 SLC38A1 SLC38A2 CACNG8 CACNG7 SLC12A9 KCNH1 SLC28A1 SLC9A7 CACNG4 SLC23A2 SLC29A1 | 1.36e-12 | 465 | 169 | 24 | GO:0046873 |
| GeneOntologyMolecularFunction | symporter activity | SLC24A5 SLC4A8 SLC6A17 SLC1A7 SLC38A1 SLC38A2 SLC16A5 SLC16A4 SLC16A3 SLC12A9 SLC16A14 SLC28A1 CTNS SLC23A2 SLC29A1 | 2.64e-12 | 150 | 169 | 15 | GO:0015293 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC24A5 CACNA1S SLC9A8 ATP6V0B SLC4A8 SLC39A9 SLC39A11 SLC25A14 TTYH2 SLC38A5 SLC1A7 RYR2 RYR3 CACNG3 CACNG2 SLC30A7 SLC38A1 SLC38A2 CACNG8 CACNG7 SLC16A3 SLC12A9 P2RX2 KCNH1 SLC28A1 SLC9A7 CACNG4 CTNS SLC23A2 SLC29A1 | 4.80e-12 | 793 | 169 | 30 | GO:0015075 |
| GeneOntologyMolecularFunction | antiporter activity | SLC24A5 SLC37A1 SLC25A24 SLC9A8 SLC4A8 SLC37A3 SLC25A14 SLC22A11 SLC38A5 SLC44A4 SLC35A3 SLC9A7 SLC35B1 | 1.70e-10 | 138 | 169 | 13 | GO:0015297 |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | SLC37A1 SLC25A24 SLC37A3 SLC35A3 SLC50A1 SLC22A2 SLC28A1 SLC29A1 SLC35B1 | 1.57e-09 | 59 | 169 | 9 | GO:1901505 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC38A5 SLC1A7 ABCB1 SLC38A1 SLC38A2 SLC22A9 SLC16A5 SLC16A4 SLC16A3 SLC16A2 SLC16A14 SLC22A2 CTNS SLC23A2 | 2.66e-09 | 207 | 169 | 14 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC38A5 SLC1A7 ABCB1 SLC38A1 SLC38A2 SLC22A9 SLC16A5 SLC16A4 SLC16A3 SLC16A2 SLC16A14 SLC22A2 CTNS SLC23A2 | 2.83e-09 | 208 | 169 | 14 | GO:0005342 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC24A5 SLC9A8 ATP6V0B SLC4A8 SLC38A5 SLC1A7 SLC38A1 SLC38A2 SLC16A3 SLC12A9 SLC28A1 SLC9A7 CTNS SLC23A2 SLC29A1 | 4.38e-08 | 301 | 169 | 15 | GO:0022853 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC4A8 SLC1A7 SLC38A1 SLC38A2 SLC16A3 SLC12A9 SLC28A1 CTNS SLC23A2 SLC29A1 | 6.95e-08 | 119 | 169 | 10 | GO:0015294 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC24A5 SLC9A8 SLC4A8 SLC38A5 SLC1A7 SLC38A1 SLC38A2 SLC28A1 SLC9A7 SLC23A2 SLC29A1 | 2.36e-07 | 171 | 169 | 11 | GO:0015081 |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 2.54e-07 | 32 | 169 | 6 | GO:0005452 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 6.47e-07 | 59 | 169 | 7 | GO:0015932 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 8.70e-07 | 39 | 169 | 6 | GO:0015605 | |
| GeneOntologyMolecularFunction | calcium channel activity | SLC24A5 CACNA1S RYR2 RYR3 CACNG3 CACNG2 CACNG8 CACNG7 CACNG4 | 1.55e-06 | 129 | 169 | 9 | GO:0005262 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.38e-06 | 46 | 169 | 6 | GO:0005245 | |
| GeneOntologyMolecularFunction | azole transmembrane transporter activity | 4.64e-06 | 14 | 169 | 4 | GO:1901474 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 5.64e-06 | 81 | 169 | 7 | GO:0015370 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | SLC24A5 CACNA1S RYR2 RYR3 CACNG3 CACNG2 CACNG8 CACNG7 CACNG4 | 5.68e-06 | 151 | 169 | 9 | GO:0015085 |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 5.88e-06 | 5 | 169 | 3 | GO:0004558 | |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 8.32e-06 | 16 | 169 | 4 | GO:0015562 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 1.25e-05 | 36 | 169 | 5 | GO:0090482 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | SLC37A1 SLC25A24 SLC4A8 SLC37A3 SLC25A14 SLC22A11 TTYH2 SLC1A7 SLC12A9 | 1.55e-05 | 171 | 169 | 9 | GO:0015103 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR8I2 OR4K17 OR10Q1 OR8U3 OR10D3 OR52I1 OR4S1 OR13C9 OR51B6 OR10W1 OR51V1 OR4X1 OR5F1 OR4F6 | 1.89e-05 | 431 | 169 | 14 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR8I2 OR4K17 SLC39A9 GPR33 OR10Q1 OR8U3 PTGER2 ADGRA2 S1PR1 OR10D3 OR52I1 OR4S1 OR13C9 OR51B6 OR10W1 MTNR1B ADGRD2 OR51V1 OR4X1 OR5F1 OR4F6 | 1.93e-05 | 884 | 169 | 21 | GO:0004930 |
| GeneOntologyMolecularFunction | organophosphate:phosphate antiporter activity | 2.03e-05 | 7 | 169 | 3 | GO:0015315 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 2.03e-05 | 7 | 169 | 3 | GO:0090599 | |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1S TTYH2 SLC1A7 RYR2 RYR3 CACNG3 CACNG2 CACNG8 CACNG7 P2RX2 KCNH1 CACNG4 | 2.87e-05 | 334 | 169 | 12 | GO:0022836 |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 3.04e-05 | 43 | 169 | 5 | GO:0140828 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 3.06e-05 | 71 | 169 | 6 | GO:0015179 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 3.12e-05 | 105 | 169 | 7 | GO:0015171 | |
| GeneOntologyMolecularFunction | pyrimidine nucleoside transmembrane transporter activity | 3.23e-05 | 8 | 169 | 3 | GO:0015214 | |
| GeneOntologyMolecularFunction | lipid transporter activity | SLC22A11 ATG2B ATG2A ABCB1 ABCB4 SLC22A9 SLC22A2 PITPNM3 ABCG8 | 4.55e-05 | 196 | 169 | 9 | GO:0005319 |
| GeneOntologyMolecularFunction | L-glutamine transmembrane transporter activity | 4.82e-05 | 9 | 169 | 3 | GO:0015186 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 5.78e-05 | 49 | 169 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | nucleoside transmembrane transporter activity | 6.84e-05 | 10 | 169 | 3 | GO:0005337 | |
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 7.12e-05 | 2 | 169 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 7.71e-05 | 52 | 169 | 5 | GO:0035255 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.16e-04 | 90 | 169 | 6 | GO:0008028 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | SLC24A5 CACNA1S TTYH2 SLC1A7 RYR2 RYR3 CACNG3 CACNG2 CACNG8 CACNG7 P2RX2 KCNH1 CACNG4 | 1.50e-04 | 459 | 169 | 13 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | SLC24A5 CACNA1S TTYH2 SLC1A7 RYR2 RHD RYR3 CACNG3 CACNG2 CACNG8 CACNG7 P2RX2 KCNH1 CACNG4 | 1.57e-04 | 525 | 169 | 14 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC24A5 CACNA1S TTYH2 SLC1A7 RYR2 RHD RYR3 CACNG3 CACNG2 CACNG8 CACNG7 P2RX2 KCNH1 CACNG4 | 1.60e-04 | 526 | 169 | 14 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | SLC24A5 CACNA1S RYR2 RYR3 CACNG3 CACNG2 CACNG8 CACNG7 P2RX2 KCNH1 CACNG4 | 1.69e-04 | 343 | 169 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR8I2 OR4K17 SLC39A9 GPR33 L1CAM OR10Q1 OR8U3 PTGER2 ADGRA2 S1PR1 OR10D3 OR52I1 OR4S1 OR13C9 P2RX2 OR51B6 TLR4 OR10W1 MTNR1B ADGRD2 OR51V1 OR4X1 OR5F1 IL7R OR4F6 | 1.85e-04 | 1353 | 169 | 25 | GO:0004888 |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.88e-04 | 34 | 169 | 4 | GO:0042910 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 2.11e-04 | 35 | 169 | 4 | GO:0005343 | |
| GeneOntologyMolecularFunction | suramin binding | 2.12e-04 | 3 | 169 | 2 | GO:0043924 | |
| GeneOntologyMolecularFunction | UDP-galactose transmembrane transporter activity | 2.12e-04 | 3 | 169 | 2 | GO:0005459 | |
| GeneOntologyMolecularFunction | ceramide floppase activity | 2.12e-04 | 3 | 169 | 2 | GO:0099038 | |
| GeneOntologyMolecularFunction | glucosidase activity | 2.51e-04 | 15 | 169 | 3 | GO:0015926 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 3.08e-04 | 16 | 169 | 3 | GO:0015385 | |
| GeneOntologyMolecularFunction | alanine transmembrane transporter activity | 3.08e-04 | 16 | 169 | 3 | GO:0022858 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 3.18e-04 | 152 | 169 | 7 | GO:0022843 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.32e-04 | 109 | 169 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 3.93e-04 | 41 | 169 | 4 | GO:0015175 | |
| GeneOntologyMolecularFunction | alanine:sodium symporter activity | 4.23e-04 | 4 | 169 | 2 | GO:0015655 | |
| GeneOntologyMolecularFunction | hexose-phosphate:phosphate antiporter activity | 4.23e-04 | 4 | 169 | 2 | GO:0015526 | |
| GeneOntologyMolecularFunction | hexose phosphate transmembrane transporter activity | 4.23e-04 | 4 | 169 | 2 | GO:0015119 | |
| GeneOntologyMolecularFunction | nucleoside:sodium symporter activity | 4.23e-04 | 4 | 169 | 2 | GO:0005415 | |
| GeneOntologyMolecularFunction | cytidine transmembrane transporter activity | 4.23e-04 | 4 | 169 | 2 | GO:0015212 | |
| GeneOntologyMolecularFunction | glucose-6-phosphate transmembrane transporter activity | 4.23e-04 | 4 | 169 | 2 | GO:0015152 | |
| GeneOntologyMolecularFunction | nucleobase:monoatomic cation symporter activity | 4.23e-04 | 4 | 169 | 2 | GO:0015391 | |
| GeneOntologyMolecularFunction | pyrimidine- and adenosine-specific:sodium symporter activity | 4.23e-04 | 4 | 169 | 2 | GO:0015389 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 4.23e-04 | 4 | 169 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 4.23e-04 | 4 | 169 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | glucose 6-phosphate:phosphate antiporter activity | 4.23e-04 | 4 | 169 | 2 | GO:0061513 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 5.22e-04 | 19 | 169 | 3 | GO:0022821 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 6.24e-04 | 81 | 169 | 5 | GO:0035254 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 6.98e-04 | 83 | 169 | 5 | GO:0015101 | |
| GeneOntologyMolecularFunction | proline:sodium symporter activity | 7.00e-04 | 5 | 169 | 2 | GO:0005298 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 9.29e-04 | 182 | 169 | 7 | GO:0005244 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 9.31e-04 | 23 | 169 | 3 | GO:0005283 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 9.90e-04 | 184 | 169 | 7 | GO:0022832 | |
| GeneOntologyMolecularFunction | uridine transmembrane transporter activity | 1.04e-03 | 6 | 169 | 2 | GO:0015213 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.04e-03 | 6 | 169 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 1.06e-03 | 24 | 169 | 3 | GO:0005315 | |
| GeneOntologyMolecularFunction | zinc ion transmembrane transporter activity | 1.06e-03 | 24 | 169 | 3 | GO:0005385 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 1.12e-03 | 188 | 169 | 7 | GO:0015078 | |
| GeneOntologyMolecularFunction | lipid transfer activity | 1.38e-03 | 57 | 169 | 4 | GO:0120013 | |
| GeneOntologyMolecularFunction | thiamine transmembrane transporter activity | 1.45e-03 | 7 | 169 | 2 | GO:0015234 | |
| GeneOntologyMolecularFunction | pyrimidine nucleobase transmembrane transporter activity | 1.45e-03 | 7 | 169 | 2 | GO:0005350 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 1.50e-03 | 27 | 169 | 3 | GO:0051139 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 1.78e-03 | 61 | 169 | 4 | GO:1901682 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 1.85e-03 | 29 | 169 | 3 | GO:0005416 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 1.85e-03 | 29 | 169 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | choline transmembrane transporter activity | 1.93e-03 | 8 | 169 | 2 | GO:0015220 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 1.93e-03 | 8 | 169 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | neutral L-amino acid:sodium symporter activity | 1.93e-03 | 8 | 169 | 2 | GO:0005295 | |
| GeneOntologyMolecularFunction | L-serine transmembrane transporter activity | 2.47e-03 | 9 | 169 | 2 | GO:0015194 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 2.70e-03 | 33 | 169 | 3 | GO:0015215 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 3.06e-03 | 10 | 169 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | glycine transmembrane transporter activity | 3.06e-03 | 10 | 169 | 2 | GO:0015187 | |
| GeneOntologyMolecularFunction | channel regulator activity | 3.69e-03 | 174 | 169 | 6 | GO:0016247 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC37A1 SLC25A24 SLC52A1 SLC4A8 SLC37A3 SLC6A17 SLC22A11 TTYH2 SLC38A5 SLC44A4 SLC22A24 SLC1A7 SLC2A3 ABCB1 ABCB4 SLC38A1 SLC38A2 SLC22A9 SLC35A3 NF1 SLC16A5 SLC16A4 SLC16A3 SLC25A40 SLC16A2 SLC16A14 SLC22A2 CTNS SLC23A2 SLC35B1 | 1.72e-17 | 515 | 167 | 30 | GO:0015711 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC24A5 SLC37A1 CACNA1S SLC9A8 ATP6V0B ABCB7 SLC4A8 SLC37A3 SLC39A9 SLC39A11 SLC6A17 SLC25A14 TTYH2 SLC38A5 SLC1A7 RYR2 RHD RYR3 CACNG3 CACNG2 SLC30A7 SLC38A1 SLC38A2 CACNG8 CACNG7 SLC12A9 P2RX2 KCNH1 SLC9A7 CACNG4 CTNS NNT SLC23A2 | 6.68e-12 | 1017 | 167 | 33 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC24A5 CACNA1S SLC9A8 ATP6V0B ABCB7 SLC4A8 SLC39A9 SLC39A11 SLC6A17 SLC25A14 SLC22A11 TTYH2 SLC38A5 SLC22A24 SLC1A7 RYR2 RYR3 ABCB1 CACNG3 CACNG2 SLC30A7 SLC38A1 SLC38A2 SLC22A9 CACNG8 CACNG7 SLC12A9 P2RX2 KCNH1 SLC22A2 SLC9A7 CACNG4 CTNS NNT SLC23A2 SLC22A31 | 2.67e-10 | 1374 | 167 | 36 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC24A5 CACNA1S SLC9A8 ATP6V0B ABCB7 SLC4A8 SLC39A9 SLC39A11 SLC6A17 SLC25A14 SLC38A5 RYR2 RHD RYR3 CACNG3 CACNG2 SLC30A7 SLC38A1 SLC38A2 CACNG8 CACNG7 SLC12A9 P2RX2 KCNH1 SLC9A7 CACNG4 CTNS NNT SLC23A2 | 3.17e-10 | 922 | 167 | 29 | GO:0098662 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC6A17 SLC22A11 TTYH2 SLC38A5 SLC1A7 ABCB1 ABCB4 SLC38A1 SLC38A2 SLC22A9 NF1 SLC16A5 SLC16A4 SLC16A3 SLC16A2 SLC16A14 SLC22A2 CTNS SLC23A2 | 1.01e-09 | 410 | 167 | 19 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC6A17 SLC22A11 TTYH2 SLC38A5 SLC1A7 ABCB1 ABCB4 SLC38A1 SLC38A2 SLC22A9 NF1 SLC16A5 SLC16A4 SLC16A3 SLC16A2 SLC16A14 SLC22A2 CTNS SLC23A2 | 1.09e-09 | 412 | 167 | 19 | GO:0015849 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC24A5 CACNA1S SLC9A8 ATP6V0B ABCB7 SLC4A8 SLC39A9 SLC39A11 SLC6A17 SLC25A14 TTYH2 SLC38A5 SLC1A7 RYR2 RYR3 ABCB1 CACNG3 CACNG2 SLC30A7 SLC38A1 SLC38A2 CACNG8 CACNG7 SLC12A9 P2RX2 KCNH1 SLC9A7 CACNG4 CTNS NNT SLC23A2 | 1.43e-09 | 1115 | 167 | 31 | GO:0034220 |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport, postsynaptic endosome to lysosome | 1.80e-09 | 8 | 167 | 5 | GO:0098943 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | SLC4A8 SLC6A17 SLC38A5 SLC2A3 ABCB1 SLC38A1 SLC38A2 SLC16A2 SLC22A2 SLC29A1 | 2.16e-09 | 87 | 167 | 10 | GO:0150104 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC24A5 CACNA1S SLC9A8 ATP6V0B ABCB7 SLC4A8 SLC39A9 SLC39A11 SLC6A17 SLC25A14 SLC38A5 RYR2 RYR3 CACNG3 CACNG2 SLC30A7 SLC38A1 SLC38A2 CACNG8 CACNG7 SLC12A9 P2RX2 KCNH1 SLC9A7 CACNG4 CTNS NNT SLC23A2 | 2.35e-09 | 942 | 167 | 28 | GO:0098655 |
| GeneOntologyBiologicalProcess | vascular transport | SLC4A8 SLC6A17 SLC38A5 SLC2A3 ABCB1 SLC38A1 SLC38A2 SLC16A2 SLC22A2 SLC29A1 | 2.42e-09 | 88 | 167 | 10 | GO:0010232 |
| GeneOntologyBiologicalProcess | neurotransmitter receptor diffusion trapping | 4.00e-08 | 13 | 167 | 5 | GO:0099628 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor diffusion trapping | 4.00e-08 | 13 | 167 | 5 | GO:0098970 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC24A5 CACNA1S SLC9A8 ATP6V0B ABCB7 SLC4A8 SLC39A9 SLC39A11 SLC6A17 SLC25A14 SLC38A5 RYR2 RYR3 CACNG3 CACNG2 SLC30A7 SLC38A1 SLC38A2 CACNG8 CACNG7 SLC12A9 P2RX2 KCNH1 SLC22A2 SLC9A7 CACNG4 CTNS NNT SLC23A2 | 5.14e-08 | 1157 | 167 | 29 | GO:0006812 |
| GeneOntologyBiologicalProcess | receptor diffusion trapping | 6.18e-08 | 14 | 167 | 5 | GO:0098953 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound transmembrane transport | 1.33e-07 | 16 | 167 | 5 | GO:0072531 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | SLC6A17 TTYH2 SLC38A5 SLC1A7 SLC38A1 SLC38A2 NF1 SLC22A2 CTNS | 2.37e-07 | 108 | 167 | 9 | GO:0015807 |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 3.24e-07 | 112 | 167 | 9 | GO:0019226 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | SLC37A1 SLC25A24 SLC37A3 SLC25A33 SLC44A4 ABCB1 ABCB4 PITPNM3 ABCG8 SLC35B1 | 8.30e-07 | 162 | 167 | 10 | GO:0015748 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | TTYH2 SLC38A5 SLC1A7 ABCB1 SLC38A1 SLC38A2 SLC22A9 SLC16A3 SLC22A2 SLC23A2 | 8.78e-07 | 163 | 167 | 10 | GO:1905039 |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | TTYH2 SLC38A5 SLC1A7 ABCB1 SLC38A1 SLC38A2 SLC22A9 SLC16A3 SLC22A2 SLC23A2 | 1.10e-06 | 167 | 167 | 10 | GO:1903825 |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | SLC37A1 SLC25A24 SLC37A3 SLC35A3 SLC50A1 SLC28A1 SLC29A1 SLC35B1 | 1.13e-06 | 96 | 167 | 8 | GO:1901264 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR8I2 OR4K17 OR10Q1 OR8U3 RYR2 OR10D3 OR52I1 OR4S1 OR13C9 P2RX2 OR51B6 TLR4 OR10W1 OR51V1 OR4X1 OR5F1 OR4F6 | 1.30e-06 | 524 | 167 | 17 | GO:0009593 |
| GeneOntologyBiologicalProcess | neurotransmitter transport | SLC4A8 SLC6A17 SLC1A7 SLC38A1 SLC38A2 SNCAIP NF1 P2RX2 KCNH1 SLC22A2 SLC29A1 RHOT1 | 1.40e-06 | 259 | 167 | 12 | GO:0006836 |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 1.53e-06 | 25 | 167 | 5 | GO:2000311 | |
| GeneOntologyBiologicalProcess | receptor localization to synapse | 1.66e-06 | 101 | 167 | 8 | GO:0097120 | |
| GeneOntologyBiologicalProcess | metal ion transport | SLC24A5 CACNA1S SLC9A8 ABCB7 SLC4A8 SLC39A9 SLC39A11 SLC6A17 SLC38A5 RYR2 RYR3 CACNG3 CACNG2 SLC30A7 SLC38A1 SLC38A2 CACNG8 CACNG7 SLC12A9 P2RX2 KCNH1 SLC9A7 CACNG4 SLC23A2 | 1.80e-06 | 1000 | 167 | 24 | GO:0030001 |
| GeneOntologyBiologicalProcess | neurotransmitter receptor localization to postsynaptic specialization membrane | 2.70e-06 | 49 | 167 | 6 | GO:0099645 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic specialization membrane | 2.70e-06 | 49 | 167 | 6 | GO:0099633 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic membrane | 3.00e-06 | 77 | 167 | 7 | GO:1903539 | |
| GeneOntologyBiologicalProcess | protein localization to postsynapse | 3.89e-06 | 80 | 167 | 7 | GO:0062237 | |
| GeneOntologyBiologicalProcess | amino acid transport | SLC6A17 TTYH2 SLC38A5 SLC1A7 SLC38A1 SLC38A2 NF1 SLC16A2 SLC22A2 CTNS | 4.43e-06 | 195 | 167 | 10 | GO:0006865 |
| GeneOntologyBiologicalProcess | L-glutamine import across plasma membrane | 5.15e-06 | 5 | 167 | 3 | GO:1903803 | |
| GeneOntologyBiologicalProcess | azole transmembrane transport | 5.28e-06 | 15 | 167 | 4 | GO:0045117 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 8.98e-06 | 60 | 167 | 6 | GO:0015804 | |
| GeneOntologyBiologicalProcess | alanine transport | 1.16e-05 | 18 | 167 | 4 | GO:0032328 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR8I2 OR4K17 OR10Q1 OR8U3 OR10D3 OR52I1 OR4S1 OR13C9 OR51B6 OR10W1 OR51V1 OR4X1 OR5F1 OR4F6 | 1.19e-05 | 432 | 167 | 14 | GO:0050911 |
| GeneOntologyBiologicalProcess | xenobiotic transport | 1.31e-05 | 64 | 167 | 6 | GO:0042908 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to vacuole | 1.57e-05 | 66 | 167 | 6 | GO:0072666 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | SLC37A1 SLC4A8 SLC37A3 SLC25A14 SLC22A11 TTYH2 SLC1A7 ABCB1 SLC12A9 | 1.65e-05 | 180 | 167 | 9 | GO:0015698 |
| GeneOntologyBiologicalProcess | import across plasma membrane | CACNA1S SLC39A11 SLC38A5 SLC2A3 SLC38A1 SLC38A2 SLC16A2 SLC22A2 SLC28A1 SLC9A7 | 1.88e-05 | 230 | 167 | 10 | GO:0098739 |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport | 2.19e-05 | 42 | 167 | 5 | GO:0099637 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR8I2 OR4K17 OR10Q1 OR8U3 TMEM107 RYR2 OR10D3 OR52I1 OR4S1 OR13C9 P2RX2 OR51B6 TLR4 OR10W1 OR51V1 OR4X1 OR5F1 OR4F6 | 2.38e-05 | 722 | 167 | 18 | GO:0051606 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 2.46e-05 | 43 | 167 | 5 | GO:0051968 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | SLC4A8 SLC6A17 SLC38A5 SVEP1 SLC2A3 ABCB1 SLC38A1 SLC38A2 SLC16A2 SLC22A2 MTNR1B SLC29A1 | 2.49e-05 | 344 | 167 | 12 | GO:0003018 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR8I2 OR4K17 OR10Q1 OR8U3 OR10D3 OR52I1 OR4S1 OR13C9 OR51B6 OR10W1 OR51V1 OR4X1 OR5F1 OR4F6 | 2.68e-05 | 465 | 167 | 14 | GO:0007608 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR8I2 OR4K17 OR10Q1 OR8U3 OR10D3 OR52I1 OR4S1 OR13C9 P2RX2 OR51B6 OR10W1 OR51V1 OR4X1 OR5F1 OR4F6 | 4.04e-05 | 547 | 167 | 15 | GO:0007606 |
| GeneOntologyBiologicalProcess | protein localization to synapse | 4.23e-05 | 115 | 167 | 7 | GO:0035418 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR8I2 OR4K17 OR10Q1 OR8U3 OR10D3 OR52I1 OR4S1 OR13C9 OR51B6 OR10W1 OR51V1 OR4X1 OR5F1 OR4F6 | 4.24e-05 | 485 | 167 | 14 | GO:0050907 |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter secretion | 4.99e-05 | 118 | 167 | 7 | GO:0046928 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC24A5 SLC9A8 SLC4A8 SLC6A17 SLC38A5 SLC38A1 SLC38A2 SLC9A7 SLC23A2 | 5.14e-05 | 208 | 167 | 9 | GO:0035725 |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 5.55e-05 | 120 | 167 | 7 | GO:0003333 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 5.84e-05 | 164 | 167 | 8 | GO:0099072 | |
| GeneOntologyBiologicalProcess | glutamine transport | 6.00e-05 | 10 | 167 | 3 | GO:0006868 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | SLC24A5 CACNA1S SLC9A8 ATP6V0B ABCB7 SLC4A8 SLC39A9 LAMP1 RYR2 RHD RYR3 SLC30A7 SLC12A9 P2RX2 KCNH1 SLC9A7 UPK3A | 6.12e-05 | 705 | 167 | 17 | GO:0055080 |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | SLC22A11 ABCB4 SLC22A9 SLC16A5 SLC16A4 SLC16A3 SLC16A2 SLC16A14 SLC22A2 | 6.17e-05 | 213 | 167 | 9 | GO:0015718 |
| GeneOntologyBiologicalProcess | endosome to lysosome transport | 6.21e-05 | 84 | 167 | 6 | GO:0008333 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | ZDHHC2 RAPSN SLC4A8 L1CAM SLC1A7 CACNG3 CACNG2 SLC38A1 SLC38A2 CACNG8 CACNG7 SNCAIP NF1 P2RX2 KCNH1 MTNR1B SYPL1 CACNG4 SLC29A1 RHOT1 | 6.74e-05 | 931 | 167 | 20 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | ZDHHC2 RAPSN SLC4A8 L1CAM SLC1A7 CACNG3 CACNG2 SLC38A1 SLC38A2 CACNG8 CACNG7 SNCAIP NF1 P2RX2 KCNH1 MTNR1B SYPL1 CACNG4 SLC29A1 RHOT1 | 6.74e-05 | 931 | 167 | 20 | GO:0007268 |
| GeneOntologyBiologicalProcess | chemical homeostasis | SLC24A5 CACNA1S SLC9A8 ATP6V0B ABCB7 SLC4A8 SLC39A9 LAMP1 TM6SF2 RYR2 RHD RYR3 ABCB4 SLC30A7 SLC12A9 P2RX2 KCNH1 MTNR1B SLC9A7 UPK3A CTNS NNT SLC29A1 ABCG8 | 7.07e-05 | 1249 | 167 | 24 | GO:0048878 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | SLC24A5 CACNA1S SLC9A8 ATP6V0B ABCB7 SLC4A8 SLC39A9 LAMP1 RYR2 RHD RYR3 SLC30A7 SLC12A9 P2RX2 KCNH1 SLC9A7 UPK3A | 7.52e-05 | 717 | 167 | 17 | GO:0050801 |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 7.56e-05 | 87 | 167 | 6 | GO:1902475 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | ZDHHC2 RAPSN SLC4A8 L1CAM SLC1A7 CACNG3 CACNG2 SLC38A1 SLC38A2 CACNG8 CACNG7 SNCAIP NF1 P2RX2 KCNH1 MTNR1B SYPL1 CACNG4 SLC29A1 RHOT1 | 7.57e-05 | 939 | 167 | 20 | GO:0099537 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR8I2 OR4K17 OR10Q1 OR8U3 OR10D3 OR52I1 OR4S1 OR13C9 OR51B6 TLR4 OR10W1 OR51V1 OR4X1 OR5F1 OR4F6 | 8.11e-05 | 582 | 167 | 15 | GO:0050906 |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 8.20e-05 | 11 | 167 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | protein localization to vacuole | 8.59e-05 | 89 | 167 | 6 | GO:0072665 | |
| GeneOntologyBiologicalProcess | vitamin transport | 8.97e-05 | 56 | 167 | 5 | GO:0051180 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 8.97e-05 | 56 | 167 | 5 | GO:0099601 | |
| GeneOntologyBiologicalProcess | circulatory system process | SLC4A8 SLC6A17 SLC38A5 PTGER2 SVEP1 SLC2A3 RYR2 ABCB1 SLC38A1 SLC38A2 SLC16A2 P2RX2 SLC22A2 MTNR1B TBX20 SLC23A2 SLC29A1 | 9.83e-05 | 733 | 167 | 17 | GO:0003013 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | ZDHHC2 RAPSN SLC4A8 L1CAM CACNG3 CACNG2 SLC38A1 SLC38A2 CACNG8 CACNG7 SNCAIP NF1 P2RX2 KCNH1 CACNG4 RHOT1 | 1.01e-04 | 663 | 167 | 16 | GO:0050804 |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 1.01e-04 | 132 | 167 | 7 | GO:0035249 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | ZDHHC2 RAPSN SLC4A8 L1CAM CACNG3 CACNG2 SLC38A1 SLC38A2 CACNG8 CACNG7 SNCAIP NF1 P2RX2 KCNH1 CACNG4 RHOT1 | 1.02e-04 | 664 | 167 | 16 | GO:0099177 |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 1.03e-04 | 92 | 167 | 6 | GO:0051966 | |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 1.06e-04 | 58 | 167 | 5 | GO:0089718 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor internalization | 1.06e-04 | 58 | 167 | 5 | GO:0099590 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.11e-04 | 134 | 167 | 7 | GO:0098661 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 1.22e-04 | 233 | 167 | 9 | GO:0050806 | |
| GeneOntologyBiologicalProcess | protein localization to lysosome | 1.25e-04 | 60 | 167 | 5 | GO:0061462 | |
| GeneOntologyBiologicalProcess | synaptic signaling | ZDHHC2 RAPSN SLC4A8 L1CAM SLC1A7 CACNG3 CACNG2 SLC38A1 SLC38A2 CACNG8 CACNG7 SNCAIP NF1 P2RX2 KCNH1 MTNR1B SYPL1 CACNG4 SLC29A1 RHOT1 | 1.28e-04 | 976 | 167 | 20 | GO:0099536 |
| GeneOntologyBiologicalProcess | cellular homeostasis | SLC24A5 CACNA1S SLC9A8 ATP6V0B ABCB7 SLC4A8 SLC39A9 APC LAMP1 RYR2 RYR3 SLC30A7 SLC12A9 P2RX2 KCNH1 SLC9A7 NNT SLC29A1 IL7R RHOT1 | 1.37e-04 | 981 | 167 | 20 | GO:0019725 |
| GeneOntologyBiologicalProcess | Golgi lumen acidification | 1.40e-04 | 13 | 167 | 3 | GO:0061795 | |
| GeneOntologyBiologicalProcess | vacuolar transport | 1.46e-04 | 187 | 167 | 8 | GO:0007034 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 1.53e-04 | 141 | 167 | 7 | GO:0051588 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.78e-04 | 14 | 167 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | serine import across plasma membrane | 1.94e-04 | 3 | 167 | 2 | GO:0098718 | |
| GeneOntologyBiologicalProcess | L-serine import across plasma membrane | 1.94e-04 | 3 | 167 | 2 | GO:1903812 | |
| GeneOntologyBiologicalProcess | regulation of Golgi lumen acidification | 1.94e-04 | 3 | 167 | 2 | GO:1905526 | |
| GeneOntologyBiologicalProcess | ceramide translocation | 1.94e-04 | 3 | 167 | 2 | GO:0099040 | |
| GeneOntologyBiologicalProcess | UDP-galactose transmembrane transport | 1.94e-04 | 3 | 167 | 2 | GO:0072334 | |
| GeneOntologyBiologicalProcess | amino acid import | 1.94e-04 | 3 | 167 | 2 | GO:0043090 | |
| GeneOntologyBiologicalProcess | glucan catabolic process | 1.99e-04 | 36 | 167 | 4 | GO:0009251 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 2.07e-04 | 148 | 167 | 7 | GO:1902414 | |
| GeneOntologyBiologicalProcess | glycine transport | 2.21e-04 | 15 | 167 | 3 | GO:0015816 | |
| GeneOntologyBiologicalProcess | lysosomal transport | 2.34e-04 | 151 | 167 | 7 | GO:0007041 | |
| GeneOntologyBiologicalProcess | polysaccharide catabolic process | 2.47e-04 | 38 | 167 | 4 | GO:0000272 | |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 3.02e-04 | 40 | 167 | 4 | GO:0072530 | |
| GeneOntologyBiologicalProcess | disaccharide catabolic process | 3.87e-04 | 4 | 167 | 2 | GO:0046352 | |
| GeneOntologyBiologicalProcess | cytidine transport | 3.87e-04 | 4 | 167 | 2 | GO:0015861 | |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC24A5 SLC9A8 SLC4A8 SLC6A17 SLC38A5 SLC38A1 SLC38A2 SLC9A7 SLC23A2 | 4.18e-04 | 275 | 167 | 9 | GO:0006814 |
| GeneOntologyBiologicalProcess | quaternary ammonium group transport | 4.59e-04 | 19 | 167 | 3 | GO:0015697 | |
| GeneOntologyCellularComponent | apical plasma membrane | TNIK OTOA MGAM SLC9A8 SLC4A8 SLC22A11 SI SLC44A4 ABCB1 ABCB4 SLC38A1 SLC16A3 SLC16A2 P2RX2 SLC22A2 CSPG4 SLC28A1 UPK3A SLC23A2 SLC29A1 ABCG8 | 4.08e-10 | 487 | 168 | 21 | GO:0016324 |
| GeneOntologyCellularComponent | apical part of cell | TNIK OTOA MGAM SLC9A8 SLC4A8 SLC22A11 SI SLC44A4 ABCB1 ABCB4 SLC38A1 SLC16A3 SLC16A2 P2RX2 SLC22A2 CSPG4 SLC28A1 UPK3A SLC23A2 SLC29A1 ABCG8 | 1.30e-08 | 592 | 168 | 21 | GO:0045177 |
| GeneOntologyCellularComponent | calcium channel complex | 1.27e-07 | 73 | 168 | 8 | GO:0034704 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ZDHHC2 MGAM IRGM VPS11 SLC9A8 ATP6V0B SLC4A8 CORO1C SLC6A17 WDR81 APC LAMP1 DCST2 SLC2A3 TMEM179B CACNG3 CACNG2 LRIG3 CACNG8 UBA1 MS4A3 KCNH1 SLC22A2 SBF2 TLR4 SLC9A7 SYPL1 CACNG4 CTNS IL7R | 1.72e-07 | 1307 | 168 | 30 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | ZDHHC2 MGAM IRGM VPS11 SLC9A8 ATP6V0B SLC4A8 CORO1C SLC6A17 WDR81 APC LAMP1 DCST2 SLC2A3 TMEM179B CACNG3 CACNG2 LRIG3 CACNG8 UBA1 MS4A3 KCNH1 SLC22A2 SBF2 TLR4 SLC9A7 SYPL1 CACNG4 CTNS IL7R | 2.30e-07 | 1325 | 168 | 30 | GO:0012506 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.77e-06 | 46 | 168 | 6 | GO:0005891 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 1.89e-06 | 12 | 168 | 4 | GO:1990454 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 3.83e-06 | 30 | 168 | 5 | GO:0032281 | |
| GeneOntologyCellularComponent | synaptic membrane | RAPSN SLC4A8 L1CAM NBEA SLC1A7 SLC2A3 CACNG3 CACNG2 CACNG8 CACNG7 SNCAIP SLC16A3 P2RX2 KCNH1 SLC22A2 C1QB CACNG4 | 4.95e-06 | 583 | 168 | 17 | GO:0097060 |
| GeneOntologyCellularComponent | sarcolemma | 2.39e-05 | 190 | 168 | 9 | GO:0042383 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 2.98e-05 | 45 | 168 | 5 | GO:0008328 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 5.00e-05 | 50 | 168 | 5 | GO:0098878 | |
| GeneOntologyCellularComponent | cation channel complex | 1.24e-04 | 235 | 168 | 9 | GO:0034703 | |
| GeneOntologyCellularComponent | phagophore | 1.92e-04 | 3 | 168 | 2 | GO:0061908 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 2.27e-04 | 201 | 168 | 8 | GO:0099634 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 2.84e-04 | 157 | 168 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | presynapse | TNIK VPS11 SLC4A8 SLC6A17 L1CAM APC LAMP1 S1PR1 SLC1A7 SLC2A3 SNCAIP NF1 P2RX2 KCNH1 SLC22A2 SYPL1 C1QB SLC29A1 | 2.88e-04 | 886 | 168 | 18 | GO:0098793 |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 3.26e-04 | 212 | 168 | 8 | GO:0030666 | |
| GeneOntologyCellularComponent | postsynaptic membrane | RAPSN NBEA SLC1A7 CACNG3 CACNG2 CACNG8 CACNG7 SLC16A3 KCNH1 C1QB CACNG4 | 4.50e-04 | 405 | 168 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 6.24e-04 | 179 | 168 | 7 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 6.24e-04 | 179 | 168 | 7 | GO:0030672 | |
| GeneOntologyCellularComponent | glutamatergic synapse | TNIK SLC4A8 SLC6A17 L1CAM APC NBEA SLC1A7 SLC2A3 CACNG3 CACNG2 CACNG8 CACNG7 NF1 P2RX2 C1QB CACNG4 | 9.32e-04 | 817 | 168 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | CCR4-NOT core complex | 9.43e-04 | 6 | 168 | 2 | GO:0030015 | |
| GeneOntologyCellularComponent | external side of apical plasma membrane | 9.43e-04 | 6 | 168 | 2 | GO:0098591 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1S TTYH2 RYR2 RYR3 CACNG3 CACNG2 CACNG8 CACNG7 KCNH1 CACNG4 | 9.96e-04 | 378 | 168 | 10 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1S ATP6V0B TTYH2 RYR2 RYR3 CACNG3 CACNG2 CACNG8 CACNG7 KCNH1 CACNG4 ABCG8 | 1.10e-03 | 523 | 168 | 12 | GO:1902495 |
| GeneOntologyCellularComponent | endocytic vesicle | CPNE2 IRGM VPS11 ATP6V0B LAMP1 CACNG3 CACNG2 CACNG8 CACNG4 IL7R | 1.12e-03 | 384 | 168 | 10 | GO:0030139 |
| GeneOntologyCellularComponent | endosome membrane | ZDHHC2 IRGM VPS11 SLC9A8 ATP6V0B CORO1C WDR81 LAMP1 UBA1 KCNH1 SBF2 TLR4 SLC9A7 | 1.19e-03 | 602 | 168 | 13 | GO:0010008 |
| GeneOntologyCellularComponent | postsynapse | ZDHHC2 TNIK CACNA1S RAPSN SLC6A17 APC NBEA SLC1A7 CACNG3 CACNG2 CACNG8 CACNG7 SLC16A3 P2RX2 KCNH1 C1QB CACNG4 SLC29A1 | 1.43e-03 | 1018 | 168 | 18 | GO:0098794 |
| GeneOntologyCellularComponent | ficolin-1-rich granule membrane | 1.47e-03 | 61 | 168 | 4 | GO:0101003 | |
| GeneOntologyCellularComponent | transporter complex | CACNA1S ATP6V0B TTYH2 RYR2 RYR3 CACNG3 CACNG2 CACNG8 CACNG7 KCNH1 CACNG4 ABCG8 | 1.68e-03 | 550 | 168 | 12 | GO:1990351 |
| GeneOntologyCellularComponent | proteasome regulatory particle, lid subcomplex | 1.74e-03 | 8 | 168 | 2 | GO:0008541 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.84e-03 | 277 | 168 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | Golgi membrane | ZDHHC2 IRGM SLC9A8 ATP6V0B GAL3ST1 ABCB1 ABCB4 SLC30A7 SLC35A3 SLC50A1 COG1 ZDHHC22 SLC9A7 SLC35B1 | 2.10e-03 | 721 | 168 | 14 | GO:0000139 |
| GeneOntologyCellularComponent | cerebellar mossy fiber | 2.23e-03 | 9 | 168 | 2 | GO:0044300 | |
| GeneOntologyCellularComponent | intercellular canaliculus | 2.23e-03 | 9 | 168 | 2 | GO:0046581 | |
| GeneOntologyCellularComponent | basal plasma membrane | SLC4A8 SLC22A11 SLC38A1 SLC22A9 SLC16A5 SLC16A3 SLC22A2 SLC23A2 SLC29A1 | 2.32e-03 | 354 | 168 | 9 | GO:0009925 |
| GeneOntologyCellularComponent | endosome | ZDHHC2 TNIK IRGM VPS11 SLC9A8 ATP6V0B CORO1C L1CAM WDR81 LAMP1 PANK1 S1PR1 CACNG7 UBA1 KCNH1 SBF2 TLR4 SLC9A7 CTNS | 2.70e-03 | 1167 | 168 | 19 | GO:0005768 |
| GeneOntologyCellularComponent | vacuolar membrane | IRGM VPS11 ATP6V0B SLC37A3 DRAM1 WDR81 LAMP1 TMEM179B UBA1 SBF2 CTNS | 2.72e-03 | 507 | 168 | 11 | GO:0005774 |
| GeneOntologyCellularComponent | autophagosome | 2.76e-03 | 119 | 168 | 5 | GO:0005776 | |
| GeneOntologyCellularComponent | synaptic vesicle | 3.01e-03 | 300 | 168 | 8 | GO:0008021 | |
| GeneOntologyCellularComponent | basal part of cell | SLC4A8 SLC22A11 SLC38A1 SLC22A9 SLC16A5 SLC16A3 SLC22A2 SLC23A2 SLC29A1 | 3.58e-03 | 378 | 168 | 9 | GO:0045178 |
| GeneOntologyCellularComponent | T-tubule | 3.79e-03 | 79 | 168 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | lysosomal membrane | IRGM VPS11 ATP6V0B SLC37A3 DRAM1 WDR81 LAMP1 TMEM179B UBA1 CTNS | 4.27e-03 | 462 | 168 | 10 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | IRGM VPS11 ATP6V0B SLC37A3 DRAM1 WDR81 LAMP1 TMEM179B UBA1 CTNS | 4.27e-03 | 462 | 168 | 10 | GO:0098852 |
| GeneOntologyCellularComponent | basolateral plasma membrane | SLC4A8 SLC38A1 SLC22A9 SLC16A5 SLC16A3 SLC22A2 SLC23A2 SLC29A1 | 4.44e-03 | 320 | 168 | 8 | GO:0016323 |
| GeneOntologyCellularComponent | exocytic vesicle | 4.44e-03 | 320 | 168 | 8 | GO:0070382 | |
| GeneOntologyCellularComponent | asymmetric synapse | ZDHHC2 TNIK SLC4A8 CACNG3 CACNG2 CACNG8 CACNG7 SLC16A3 KCNH1 CACNG4 | 5.33e-03 | 477 | 168 | 10 | GO:0032279 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 5.56e-03 | 88 | 168 | 4 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 5.65e-03 | 45 | 168 | 3 | GO:0033017 | |
| Domain | MFS | SLC37A1 SLC37A3 SLC22A11 SLC22A24 SLC2A3 SLC22A9 SLC16A5 SLC16A4 SLC16A3 SLC16A2 SLC16A14 SLC22A2 SLC22A31 | 1.44e-11 | 108 | 167 | 13 | PS50850 |
| Domain | MFS_dom | SLC37A1 SLC37A3 SLC22A11 SLC22A24 SLC2A3 SLC22A9 SLC16A5 SLC16A4 SLC16A3 SLC16A2 SLC16A14 SLC22A2 SLC29A1 SLC22A31 | 1.63e-11 | 134 | 167 | 14 | IPR020846 |
| Domain | MFS_1 | SLC37A1 SLC37A3 SLC22A11 SLC22A24 SLC22A9 SLC16A5 SLC16A4 SLC16A3 SLC16A2 SLC16A14 | 1.63e-09 | 77 | 167 | 10 | PF07690 |
| Domain | MFS | SLC37A1 SLC37A3 SLC22A11 SLC22A24 SLC22A9 SLC16A5 SLC16A4 SLC16A3 SLC16A2 SLC16A14 | 1.63e-09 | 77 | 167 | 10 | IPR011701 |
| Domain | VDCC_gsu | 2.95e-09 | 8 | 167 | 5 | IPR008368 | |
| Domain | Gal_mutarotase_N | 2.79e-06 | 4 | 167 | 3 | IPR031727 | |
| Domain | NtCtMGAM_N | 2.79e-06 | 4 | 167 | 3 | PF16863 | |
| Domain | Glyco_hydro_31_AS | 1.38e-05 | 6 | 167 | 3 | IPR030458 | |
| Domain | Glyco_hydro_31 | 2.39e-05 | 7 | 167 | 3 | IPR000322 | |
| Domain | Glyco_hydro_31 | 2.39e-05 | 7 | 167 | 3 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 2.39e-05 | 7 | 167 | 3 | PS00129 | |
| Domain | PMP22_Claudin | 2.75e-05 | 40 | 167 | 5 | PF00822 | |
| Domain | ABC_transporter_CS | 3.50e-05 | 42 | 167 | 5 | IPR017871 | |
| Domain | Trefoil | 3.80e-05 | 8 | 167 | 3 | PF00088 | |
| Domain | PMP22/EMP/MP20/Claudin | 4.92e-05 | 45 | 167 | 5 | IPR004031 | |
| Domain | Olfact_rcpt | OR8I2 OR4K17 OR10Q1 OR8U3 OR52I1 OR4S1 OR13C9 OR51B6 OR10W1 OR51V1 OR4X1 OR5F1 OR4F6 | 5.46e-05 | 393 | 167 | 13 | IPR000725 |
| Domain | P_TREFOIL_2 | 5.67e-05 | 9 | 167 | 3 | PS51448 | |
| Domain | PD | 5.67e-05 | 9 | 167 | 3 | SM00018 | |
| Domain | ABC_membrane | 5.70e-05 | 24 | 167 | 4 | PF00664 | |
| Domain | ABC_tran | 6.75e-05 | 48 | 167 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 6.75e-05 | 48 | 167 | 5 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 7.47e-05 | 49 | 167 | 5 | PS00211 | |
| Domain | ATG2 | 7.95e-05 | 2 | 167 | 2 | IPR026849 | |
| Domain | ATG2_CAD | 7.95e-05 | 2 | 167 | 2 | PF13329 | |
| Domain | ATG2_CAD_motif | 7.95e-05 | 2 | 167 | 2 | IPR026885 | |
| Domain | ABC_transporter-like | 8.24e-05 | 50 | 167 | 5 | IPR003439 | |
| Domain | ABC_TM1F | 1.07e-04 | 28 | 167 | 4 | PS50929 | |
| Domain | ABC1_TM_dom | 1.07e-04 | 28 | 167 | 4 | IPR011527 | |
| Domain | GPCR_Rhodpsn_7TM | OR8I2 OR4K17 GPR33 OR10Q1 OR8U3 PTGER2 S1PR1 OR52I1 OR4S1 OR13C9 OR51B6 OR10W1 MTNR1B OR51V1 OR4X1 OR5F1 OR4F6 | 1.09e-04 | 670 | 167 | 17 | IPR017452 |
| Domain | - | 1.10e-04 | 11 | 167 | 3 | 4.10.110.10 | |
| Domain | 7tm_1 | OR8I2 OR4K17 GPR33 OR10Q1 OR8U3 PTGER2 S1PR1 OR52I1 OR4S1 OR13C9 OR51B6 OR10W1 MTNR1B OR51V1 OR4X1 OR5F1 OR4F6 | 1.24e-04 | 677 | 167 | 17 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR8I2 OR4K17 GPR33 OR10Q1 OR8U3 PTGER2 S1PR1 OR52I1 OR4S1 OR13C9 OR51B6 OR10W1 MTNR1B OR51V1 OR4X1 OR5F1 OR4F6 | 1.42e-04 | 685 | 167 | 17 | PS00237 |
| Domain | P_trefoil_dom | 1.46e-04 | 12 | 167 | 3 | IPR000519 | |
| Domain | G_PROTEIN_RECEP_F1_2 | OR8I2 OR4K17 GPR33 OR10Q1 OR8U3 PTGER2 S1PR1 OR52I1 OR4S1 OR13C9 OR51B6 OR10W1 MTNR1B OR51V1 OR4X1 OR5F1 OR4F6 | 1.58e-04 | 691 | 167 | 17 | PS50262 |
| Domain | GPCR_Rhodpsn | OR8I2 OR4K17 GPR33 OR10Q1 OR8U3 PTGER2 S1PR1 OR52I1 OR4S1 OR13C9 OR51B6 OR10W1 MTNR1B OR51V1 OR4X1 OR5F1 OR4F6 | 1.60e-04 | 692 | 167 | 17 | IPR000276 |
| Domain | ConA-like_dom | 1.61e-04 | 219 | 167 | 9 | IPR013320 | |
| Domain | Ryanodine_rcpt | 2.37e-04 | 3 | 167 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 2.37e-04 | 3 | 167 | 2 | IPR009460 | |
| Domain | RyR | 2.37e-04 | 3 | 167 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 2.37e-04 | 3 | 167 | 2 | PF06459 | |
| Domain | Ryan_recept | 2.37e-04 | 3 | 167 | 2 | IPR013333 | |
| Domain | MFS_sugar_transport-like | 2.91e-04 | 36 | 167 | 4 | IPR005828 | |
| Domain | Sugar_tr | 2.91e-04 | 36 | 167 | 4 | PF00083 | |
| Domain | Gal_mutarotase_SF_dom | 4.35e-04 | 17 | 167 | 3 | IPR011013 | |
| Domain | Aa_trans | 4.35e-04 | 17 | 167 | 3 | PF01490 | |
| Domain | AA_transpt_TM | 4.35e-04 | 17 | 167 | 3 | IPR013057 | |
| Domain | Glyco_hydro_31_CS | 4.71e-04 | 4 | 167 | 2 | IPR030459 | |
| Domain | Sugar_P_transporter | 4.71e-04 | 4 | 167 | 2 | IPR000849 | |
| Domain | GLYCOSYL_HYDROL_F31_2 | 7.81e-04 | 5 | 167 | 2 | PS00707 | |
| Domain | RNase_CAF1 | 7.81e-04 | 5 | 167 | 2 | IPR006941 | |
| Domain | Autophagy-rel_C | 7.81e-04 | 5 | 167 | 2 | IPR015412 | |
| Domain | MCT | 7.81e-04 | 5 | 167 | 2 | IPR004743 | |
| Domain | ATG_C | 7.81e-04 | 5 | 167 | 2 | PF09333 | |
| Domain | CAF1 | 7.81e-04 | 5 | 167 | 2 | PF04857 | |
| Domain | RIH_assoc-dom | 1.16e-03 | 6 | 167 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.16e-03 | 6 | 167 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.16e-03 | 6 | 167 | 2 | PF08454 | |
| Domain | RIH_dom | 1.16e-03 | 6 | 167 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.16e-03 | 6 | 167 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.16e-03 | 6 | 167 | 2 | IPR015925 | |
| Domain | - | 1.16e-03 | 6 | 167 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.16e-03 | 6 | 167 | 2 | PF01365 | |
| Domain | - | 1.28e-03 | 53 | 167 | 4 | 1.50.40.10 | |
| Domain | Mito_carr | 1.28e-03 | 53 | 167 | 4 | PF00153 | |
| Domain | SOLCAR | 1.28e-03 | 53 | 167 | 4 | PS50920 | |
| Domain | Mitochondrial_sb/sol_carrier | 1.28e-03 | 53 | 167 | 4 | IPR018108 | |
| Domain | Mt_carrier_dom | 1.28e-03 | 53 | 167 | 4 | IPR023395 | |
| Domain | Claudin | 1.95e-03 | 28 | 167 | 3 | IPR006187 | |
| Domain | Chorein_N | 2.15e-03 | 8 | 167 | 2 | PF12624 | |
| Domain | P_TREFOIL_1 | 2.15e-03 | 8 | 167 | 2 | PS00025 | |
| Domain | VPS13_N | 2.15e-03 | 8 | 167 | 2 | IPR026854 | |
| Domain | P_trefoil_CS | 2.15e-03 | 8 | 167 | 2 | IPR017957 | |
| Domain | NaH_exchanger | 2.75e-03 | 9 | 167 | 2 | IPR004709 | |
| Domain | BEACH | 2.75e-03 | 9 | 167 | 2 | PS50197 | |
| Domain | Beach | 2.75e-03 | 9 | 167 | 2 | PF02138 | |
| Domain | - | 2.75e-03 | 9 | 167 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.75e-03 | 9 | 167 | 2 | SM01026 | |
| Domain | BEACH_dom | 2.75e-03 | 9 | 167 | 2 | IPR000409 | |
| Domain | Mit_carrier | 2.88e-03 | 32 | 167 | 3 | IPR002067 | |
| Domain | MIR | 3.41e-03 | 10 | 167 | 2 | PF02815 | |
| Domain | MIR_motif | 3.41e-03 | 10 | 167 | 2 | IPR016093 | |
| Domain | MIR | 3.41e-03 | 10 | 167 | 2 | PS50919 | |
| Domain | MIR | 3.41e-03 | 10 | 167 | 2 | SM00472 | |
| Domain | Pentaxin-related | 4.15e-03 | 11 | 167 | 2 | IPR001759 | |
| Domain | Pentaxin | 4.15e-03 | 11 | 167 | 2 | PF00354 | |
| Domain | Cation/H_exchanger_CPA1 | 4.15e-03 | 11 | 167 | 2 | IPR018422 | |
| Domain | DUF4599 | 4.95e-03 | 12 | 167 | 2 | PF15371 | |
| Domain | DUF4599 | 4.95e-03 | 12 | 167 | 2 | IPR027970 | |
| Domain | MS4A | 6.74e-03 | 14 | 167 | 2 | IPR030417 | |
| Domain | ZIP | 6.74e-03 | 14 | 167 | 2 | IPR003689 | |
| Domain | Na_H_Exchanger | 6.74e-03 | 14 | 167 | 2 | PF00999 | |
| Domain | Zip | 6.74e-03 | 14 | 167 | 2 | PF02535 | |
| Domain | Cation/H_exchanger | 6.74e-03 | 14 | 167 | 2 | IPR006153 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC24A5 SLC9A8 SLC4A8 SLC22A11 SLC38A5 SLC44A4 SLC1A7 SLC2A3 SLC38A1 SLC38A2 SLC35A3 SLC16A3 SLC50A1 SLC16A2 SLC22A2 SLC28A1 SLC9A7 CTNS SLC29A1 | 2.62e-12 | 249 | 135 | 19 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC24A5 SLC9A8 ATP6V0B ABCB7 SLC4A8 ABCB5 TTYH2 SLC38A5 PSMD8 SLC44A4 SLC1A7 SLC2A3 RYR2 RYR3 ABCB1 ABCB4 SLC38A1 SLC38A2 SLC35A3 ERLIN2 SLC16A3 SLC50A1 SLC16A2 SLC22A2 SLC28A1 SLC9A7 CTNS SLC29A1 ABCG8 | 7.93e-12 | 681 | 135 | 29 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC24A5 SLC9A8 ATP6V0B ABCB7 SLC4A8 ABCB5 SLC22A11 TTYH2 SLC38A5 PSMD8 SLC44A4 SLC1A7 SLC2A3 RYR2 RYR3 ABCB1 ABCB4 SLC38A1 SLC38A2 SLC35A3 ERLIN2 SLC16A3 SLC50A1 SLC16A2 SLC22A2 SLC28A1 SLC9A7 CTNS SLC29A1 ABCG8 | 9.69e-12 | 736 | 135 | 30 | M27287 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC24A5 SLC9A8 SLC4A8 SLC38A5 SLC44A4 SLC1A7 SLC2A3 SLC38A1 SLC38A2 SLC35A3 SLC16A3 SLC50A1 SLC16A2 SLC22A2 SLC28A1 SLC9A7 CTNS SLC29A1 | 1.20e-11 | 238 | 135 | 18 | MM15076 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC24A5 SLC9A8 SLC4A8 SLC38A5 SLC1A7 SLC38A1 SLC38A2 SLC9A7 CTNS | 9.10e-07 | 108 | 135 | 9 | M823 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC24A5 SLC9A8 SLC4A8 SLC38A5 SLC1A7 SLC38A1 SLC38A2 SLC9A7 CTNS | 9.84e-07 | 109 | 135 | 9 | MM15074 |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 1.35e-06 | 21 | 135 | 5 | M47950 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING | 1.35e-06 | 21 | 135 | 5 | M47949 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 3.41e-06 | 25 | 135 | 5 | M47948 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 6.67e-06 | 74 | 135 | 7 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 6.67e-06 | 74 | 135 | 7 | M39462 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 7.47e-06 | 14 | 135 | 4 | MM15277 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 7.47e-06 | 14 | 135 | 4 | M27564 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 1.03e-05 | 79 | 135 | 7 | M17673 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.43e-05 | 83 | 135 | 7 | M8728 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 2.44e-05 | 90 | 135 | 7 | M835 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 4.52e-05 | 99 | 135 | 7 | MM14986 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR8I2 OR4K17 OR10Q1 OR8U3 OR10D3 OR52I1 OR4S1 OR13C9 OR51B6 OR10W1 OR51V1 OR4X1 OR5F1 OR4F6 | 4.64e-05 | 417 | 135 | 14 | M4072 |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 4.64e-05 | 8 | 135 | 3 | MM15197 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 5.83e-05 | 103 | 135 | 7 | M758 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 6.02e-05 | 44 | 135 | 5 | M11911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.34e-04 | 11 | 135 | 3 | M47958 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.59e-04 | 29 | 135 | 4 | MM15028 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 2.07e-04 | 31 | 135 | 4 | M7223 | |
| Pathway | REACTOME_PHASE_2_PLATEAU_PHASE | 2.89e-04 | 14 | 135 | 3 | MM15198 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 3.01e-04 | 177 | 135 | 8 | M27476 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR8I2 OR4K17 OR10Q1 OR8U3 OR52I1 OR4S1 OR13C9 OR51B6 OR51V1 OR4X1 OR5F1 OR4F6 | 3.59e-04 | 389 | 135 | 12 | M14091 |
| Pathway | REACTOME_PHASE_2_PLATEAU_PHASE | 3.59e-04 | 15 | 135 | 3 | M27456 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 6.19e-04 | 41 | 135 | 4 | MM15075 | |
| Pathway | WP_GPCRS_SMALL_LIGAND | 6.31e-04 | 18 | 135 | 3 | MM15858 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 7.43e-04 | 43 | 135 | 4 | M881 | |
| Pathway | WP_SMALL_LIGAND_GPCRS | 7.44e-04 | 19 | 135 | 3 | M39728 | |
| Pathway | REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT | 8.93e-04 | 5 | 135 | 2 | M27147 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 9.62e-04 | 211 | 135 | 8 | MM14502 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | NBEA SLC1A7 CACNG3 CACNG2 SLC38A1 SLC38A2 CACNG8 SLC22A2 CACNG4 | 1.16e-03 | 270 | 135 | 9 | M15514 |
| Pathway | BIOCARTA_MRP_PATHWAY | 1.33e-03 | 6 | 135 | 2 | M22078 | |
| Pubmed | Calcium channel gamma subunits: a functionally diverse protein family. | 1.46e-10 | 8 | 170 | 5 | 17652770 | |
| Pubmed | 3.26e-10 | 9 | 170 | 5 | 11170751 | ||
| Pubmed | Functional modulation of AMPA receptors by transmembrane AMPA receptor regulatory proteins. | 5.51e-10 | 4 | 170 | 4 | 18304745 | |
| Pubmed | Critical role for TARPs in early development despite broad functional redundancy. | 5.51e-10 | 4 | 170 | 4 | 18634809 | |
| Pubmed | SLC4A8 SLC6A17 SLC38A5 ABCB1 SLC38A1 SLC38A2 SLC16A2 SLC22A2 SLC29A1 | 2.59e-09 | 105 | 170 | 9 | 30280653 | |
| Pubmed | 2.74e-09 | 5 | 170 | 4 | 9425115 | ||
| Pubmed | 5.08e-09 | 14 | 170 | 5 | 12739169 | ||
| Pubmed | 6.55e-09 | 52 | 170 | 7 | 26590417 | ||
| Pubmed | Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins. | 3.80e-08 | 8 | 170 | 4 | 21172611 | |
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 14505496 | ||
| Pubmed | A targeted mutation in Cacng4 exacerbates spike-wave seizures in stargazer (Cacng2) mice. | 1.15e-07 | 3 | 170 | 3 | 15677329 | |
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 9542318 | ||
| Pubmed | Cardiac L-type calcium channel (Cav1.2) associates with gamma subunits. | 4.57e-07 | 4 | 170 | 3 | 21127204 | |
| Pubmed | The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. | 4.57e-07 | 4 | 170 | 3 | 10510291 | |
| Pubmed | ATP6V0B ABCB5 UBQLN4 PSMD8 RBM39 SVEP1 SLC2A3 UBA1 COG1 PCNX4 MTNR1B | 6.04e-07 | 322 | 170 | 11 | 26514267 | |
| Pubmed | OR8I2 OR4K17 OR10Q1 OR8U3 OR10D3 OR52I1 OR4S1 OR13C9 OR10W1 OR51V1 OR4X1 OR5F1 OR4F6 | 2.92e-06 | 541 | 170 | 13 | 14983052 | |
| Pubmed | 3.09e-06 | 21 | 170 | 4 | 23137377 | ||
| Pubmed | TNIK SLC4A8 ADRM1 CORO1C ATG2B APC NBEA RBM39 RYR2 CACNG3 CACNG2 CACNG8 UBA1 ERLIN2 CCDC88A NF1 SUGT1 PITPNM3 HADHB | 3.44e-06 | 1139 | 170 | 19 | 36417873 | |
| Pubmed | Calcium channel gamma subunits provide insights into the evolution of this gene family. | 3.96e-06 | 7 | 170 | 3 | 11738816 | |
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 27076426 | ||
| Pubmed | 6.31e-06 | 8 | 170 | 3 | 25762662 | ||
| Pubmed | 6.31e-06 | 8 | 170 | 3 | 31570606 | ||
| Pubmed | Altered placental function of 11beta-hydroxysteroid dehydrogenase 2 knockout mice. | 9.43e-06 | 9 | 170 | 3 | 18845627 | |
| Pubmed | Accumulation of AMPA receptors in autophagosomes in neuronal axons lacking adaptor protein AP-4. | 1.84e-05 | 11 | 170 | 3 | 18341993 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 10488067 | ||
| Pubmed | Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. | 2.38e-05 | 2 | 170 | 2 | 21705081 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 28800131 | ||
| Pubmed | Conservation of the deadenylase activity of proteins of the Caf1 family in human. | 2.38e-05 | 2 | 170 | 2 | 15769875 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 10552998 | ||
| Pubmed | Genetic dissection of the function of mammalian P-glycoproteins. | 2.38e-05 | 2 | 170 | 2 | 9196326 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22219374 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 17880893 | ||
| Pubmed | TARP subtypes differentially and dose-dependently control synaptic AMPA receptor gating. | 2.38e-05 | 2 | 170 | 2 | 17880894 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 27177126 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 8898203 | ||
| Pubmed | TARP redundancy is critical for maintaining AMPA receptor function. | 2.38e-05 | 2 | 170 | 2 | 18753375 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 24278135 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 2473069 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19185004 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 8898078 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 20734919 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 32164327 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 14550562 | ||
| Pubmed | PDZ binding of TARPγ-8 controls synaptic transmission but not synaptic plasticity. | 2.38e-05 | 2 | 170 | 2 | 22002768 | |
| Pubmed | Biliary secretion of alpha-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice. | 2.38e-05 | 2 | 170 | 2 | 9473291 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 2471060 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 23408887 | ||
| Pubmed | MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells. | 2.38e-05 | 2 | 170 | 2 | 18231753 | |
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 2.38e-05 | 2 | 170 | 2 | 21531043 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 16678258 | ||
| Pubmed | ABCB1/4 gallbladder cancer risk variants identified in India also show strong effects in Chileans. | 2.38e-05 | 2 | 170 | 2 | 32058310 | |
| Pubmed | ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription. | 2.38e-05 | 2 | 170 | 2 | 33084574 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 24804815 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 3768958 | ||
| Pubmed | CNOT7 Outcompetes Its Paralog CNOT8 for Integration into The CCR4-NOT Complex. | 2.38e-05 | 2 | 170 | 2 | 35248544 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 27480812 | ||
| Pubmed | Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice. | 2.38e-05 | 2 | 170 | 2 | 38522903 | |
| Pubmed | Localization of the human multiple drug resistance gene, MDR1, to 7q21.1. | 2.38e-05 | 2 | 170 | 2 | 3477522 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 16857572 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 12097333 | ||
| Pubmed | Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. | 2.38e-05 | 2 | 170 | 2 | 9419367 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 2248681 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 17440929 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 23318418 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 25406319 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 11826402 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 34844236 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 10453001 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 12807720 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 28441502 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22184139 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 17854600 | ||
| Pubmed | Isolation and expression of a complementary DNA that confers multidrug resistance. | 2.38e-05 | 2 | 170 | 2 | 3022150 | |
| Pubmed | Role of APC-mediated MDR-1/CLCX-1 signaling pathway in ovarian tumors. | 2.38e-05 | 2 | 170 | 2 | 29921377 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 2570420 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 34822124 | ||
| Pubmed | TARP γ-7 selectively enhances synaptic expression of calcium-permeable AMPARs. | 2.38e-05 | 2 | 170 | 2 | 23872597 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 11101640 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 28274756 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22644860 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 10221464 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 18215618 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 29150444 | ||
| Pubmed | What have we learnt thus far from mice with disrupted P-glycoprotein genes? | 2.38e-05 | 2 | 170 | 2 | 8763339 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 18600541 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 27391331 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 30847922 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 36968271 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19605561 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 20004025 | ||
| Pubmed | ABCB1 transporter and Toll-like receptor 4 in trabecular meshwork cells. | 2.38e-05 | 2 | 170 | 2 | 25802484 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 20356844 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 1969609 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 24140176 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 32312148 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 17101733 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 15701712 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 27562646 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 7832992 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 31239287 | ||
| Interaction | TMEM237 interactions | SLC52A1 SLC39A9 TMEM254 WDR81 LAMP1 TMEM107 TM6SF2 RHD TMEM179B SLC38A2 SLC16A4 | 4.80e-07 | 202 | 155 | 11 | int:TMEM237 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | OR8I2 OR10Q1 OR8U3 MS4A15 SLC22A24 TMEM179B SLC22A9 MS4A3 OR10W1 OR5F1 | 7.39e-07 | 345 | 170 | 10 | chr11q12 |
| Cytoband | 11q12.1 | 3.23e-05 | 161 | 170 | 6 | 11q12.1 | |
| Cytoband | 7q21.12 | 3.76e-04 | 8 | 170 | 2 | 7q21.12 | |
| GeneFamily | Solute carriers | SLC24A5 SLC37A1 SLC25A24 SLC9A8 SLC52A1 SLC4A8 SLC37A3 SLC39A9 SLC39A11 SLC25A33 SLC6A17 SLC25A14 SLC22A11 SLC38A5 SLC44A4 SLC22A24 SLC1A7 SLC2A3 SLC30A7 SLC38A1 SLC38A2 SLC22A9 SLC35A3 SLC16A5 SLC16A4 SLC16A3 SLC25A40 SLC12A9 SLC50A1 SLC16A2 SLC16A14 SLC22A2 SLC28A1 SLC9A7 SLC23A2 SLC29A1 SLC35B1 SLC22A31 | 2.16e-32 | 395 | 130 | 38 | 752 |
| GeneFamily | Calcium voltage-gated channel subunits | 2.52e-08 | 26 | 130 | 6 | 253 | |
| GeneFamily | ATP binding cassette subfamily B | 8.10e-07 | 11 | 130 | 4 | 806 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.53e-04 | 3 | 130 | 2 | 287 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.79e-03 | 9 | 130 | 2 | 1230 | |
| GeneFamily | CCR4-NOT transcription complex | 2.70e-03 | 11 | 130 | 2 | 1023 | |
| ToppCell | TCGA-Kidney|World / Sample_Type by Project: Shred V9 | MGAM GAL3ST1 SLC22A11 SLC22A24 SLC16A4 HOGA1 SLC22A2 SLC28A1 | 1.13e-07 | 151 | 168 | 8 | e31974c0d0a0c644205a0ee6013ab74a09d8a306 |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.11e-07 | 184 | 168 | 8 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.55e-07 | 186 | 168 | 8 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.78e-07 | 187 | 168 | 8 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.69e-06 | 161 | 168 | 7 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | COVID-CD8-CD8_2|COVID / Condition, Cell_class and T cell subcluster | 2.69e-06 | 161 | 168 | 7 | 307dcc17475413cd9eb70c27bc447f938ee5723d | |
| ToppCell | C_02|World / shred on cell type and cluster | 3.16e-06 | 165 | 168 | 7 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-06 | 172 | 168 | 7 | 17a486c5d0430abb133eab9f087e2ef8b60f7d25 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Erythrophagocytic_macrophages|Lung / Manually curated celltypes from each tissue | 5.21e-06 | 178 | 168 | 7 | b63cee443cc1b7416112bf610d7c9d41e4fa37ed | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.95e-06 | 186 | 168 | 7 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 8.55e-06 | 192 | 168 | 7 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.78e-06 | 196 | 168 | 7 | 646a8d47dddffdfd2d8a62245ea6cd49f9510a1a | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Luminal_Macrophages|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.01e-05 | 197 | 168 | 7 | 523a7f363c7ba8c196ea6e4f7544c29c18c10b51 | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 1.01e-05 | 197 | 168 | 7 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 198 | 168 | 7 | 3b4611c9ee4d42e042a29ddb4580a95938d87d65 | |
| ToppCell | COVID-19-Myeloid-Alveolar_macrophages|COVID-19 / group, cell type (main and fine annotations) | 1.08e-05 | 199 | 168 | 7 | e1c85ca85fa22c4a4fa1bbdf55304bf3628485ee | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.08e-05 | 199 | 168 | 7 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.11e-05 | 200 | 168 | 7 | bbe9597f8656f9652ba0c810fd962eaa434b3200 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 200 | 168 | 7 | f0c338877e39226a90c4effe12f6501d33542a73 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.19e-05 | 149 | 168 | 6 | f4bee5fdaaa4a1917e403de90e5a62353006df24 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.19e-05 | 149 | 168 | 6 | a6c24d8f3b5f08587f0a12cd63d166b68ea000c7 | |
| ToppCell | droplet-Spleen-nan-24m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 164 | 168 | 6 | 4d8233f69ea89d4104caa56bdd0c23c27cabe9b3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.15e-05 | 167 | 168 | 6 | 063ec29b32e40aaa138a691da3a79ee8eef0c2be | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.15e-05 | 167 | 168 | 6 | 013971700e80b71e4b8c79b8fff0d8beeac295c3 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-05 | 171 | 168 | 6 | 159ce6d5513008532dd7785b915b3fe7440cc4b2 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.39e-05 | 175 | 168 | 6 | 28b29f844fa46fe579ddc19039fb2d9dc5f48f3b | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.39e-05 | 175 | 168 | 6 | ac96ca9ca309b0d72a2f5af6a3b02c7f80755750 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-05 | 176 | 168 | 6 | 4ed73c73972334f6dc4229920205547823252fa0 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.74e-05 | 177 | 168 | 6 | 4672cc75225a4a23b298afa8ce439628262519db | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.74e-05 | 177 | 168 | 6 | c9e5820ff0bc7ad1adcfb2651713fdfc58bced56 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.74e-05 | 177 | 168 | 6 | 3a150dcaefa342d49968b42c7cdb1fbb633adcd0 | |
| ToppCell | IIF-Lymphocyte-T_NK-MAIT|IIF / Disease, Lineage and Cell Type | 5.92e-05 | 178 | 168 | 6 | be777ebef8f09a1a16fcee8fc69a65ab295b6e1d | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 179 | 168 | 6 | d78eacf47847a50888dd16c35bed9b7afc80010f | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 180 | 168 | 6 | 54e3f289a37d4cfbfca4fb284c3b52e9c7d9da97 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 180 | 168 | 6 | bfc8568d57034dd9c9e07edae94479a48ca0706d | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.30e-05 | 180 | 168 | 6 | b94618c1c2592ecf7da3535294aee9243755247a | |
| ToppCell | wk_15-18-Epithelial-PNS-Late_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.69e-05 | 182 | 168 | 6 | 6462e0469224457e249d10e224082f727caa02d6 | |
| ToppCell | Control-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations) | 6.90e-05 | 183 | 168 | 6 | 8f9c8e2436f18ea7c265b08e4e149e19cb513a16 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-05 | 183 | 168 | 6 | ffb1bbbccb34d1a7e99872611f497450039d5019 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.90e-05 | 183 | 168 | 6 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-05 | 183 | 168 | 6 | 876b4f128c2168fdae7488201ff44f19c06c8415 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-05 | 183 | 168 | 6 | b190b650e61b1b20baf5e42d04acac82d3fd1400 | |
| ToppCell | Control-APC-like|Control / group, cell type (main and fine annotations) | 6.90e-05 | 183 | 168 | 6 | c313ac72cc9fa1583456d452393f61f0a4ca33a8 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.11e-05 | 184 | 168 | 6 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | CF-Myeloid-cDC|CF / Disease state, Lineage and Cell class | 7.33e-05 | 185 | 168 | 6 | 7f3d118845ff9f5f525796b0bbc6532a8ee323ab | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.00e-05 | 188 | 168 | 6 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.28e-05 | 4 | 168 | 2 | 776052094988928af65897bd748dff8a67722870 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 8.48e-05 | 190 | 168 | 6 | 9fc763d65470ba8858b973689c4d4358faab7dd3 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.73e-05 | 191 | 168 | 6 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.73e-05 | 191 | 168 | 6 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.73e-05 | 191 | 168 | 6 | 752e31a4b8aab9243b0451f4c40c2940ae9a5252 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.73e-05 | 191 | 168 | 6 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.73e-05 | 191 | 168 | 6 | 4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.99e-05 | 192 | 168 | 6 | 71bc03b08cda0382ea45b503d5f4f135ed98cc11 | |
| ToppCell | Healthy_Control-Lymphoid-T-CCR7+_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 8.99e-05 | 192 | 168 | 6 | 5b197f65a87c315e4f50c77a7fdec3b342a863ad | |
| ToppCell | (3)_Macrophage_MARCOpos|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.99e-05 | 192 | 168 | 6 | b1e2175bd4c02106e52d8f491eea1329ac327ae9 | |
| ToppCell | COPD-Myeloid|COPD / Disease state, Lineage and Cell class | 9.25e-05 | 193 | 168 | 6 | f58552e286aa27e592497ad78776f58f8ee09841 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.25e-05 | 193 | 168 | 6 | 704378de39e1b6f108ab5b0ecbd594d414ec8ae4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.51e-05 | 194 | 168 | 6 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.51e-05 | 194 | 168 | 6 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.51e-05 | 194 | 168 | 6 | 0fdf4d7d42d8f1f47eade2fb89ff35b188b9b51f | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.51e-05 | 194 | 168 | 6 | 36f8ae4f2b3bf802f6ff0e9fc79e7f170f96ae8b | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.51e-05 | 194 | 168 | 6 | 69cf7c989ac355c459db13f9d4267b55adc3c174 | |
| ToppCell | BLOOD--(1)_MAIT-like_CD8_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.51e-05 | 194 | 168 | 6 | 0064bcd9ac2fecec81f8d4e7d9f86f0089872fe7 | |
| ToppCell | Control-Myeloid|Control / Disease state, Lineage and Cell class | 9.79e-05 | 195 | 168 | 6 | 46ce2e403ca5d757e5ba17349b6c7ce5cde1f195 | |
| ToppCell | IPF-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 9.79e-05 | 195 | 168 | 6 | 50edda117b438b9c3616191884007466f6d974f0 | |
| ToppCell | IPF-Myeloid|IPF / Disease state, Lineage and Cell class | 9.79e-05 | 195 | 168 | 6 | fdeb958aeaa00f3fc25c4e59efbbc6f4a572c9ce | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 196 | 168 | 6 | 4ebcaac758ed01d918de9c1cd383a84457b615f3 | |
| ToppCell | NS-moderate-d_07-13-Myeloid|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.01e-04 | 196 | 168 | 6 | e5c7ef2f092ad082698f014f9c5ba1ff4d07b93f | |
| ToppCell | normal-na-Lymphocytic_NK-T_mait|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.03e-04 | 197 | 168 | 6 | 5abe983f9750085ec7b57bcb8c36bdfe78a6ee4c | |
| ToppCell | NS-control-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.03e-04 | 197 | 168 | 6 | 496a1115071a1be6928786192de49f3adf197dfb | |
| ToppCell | LAM-Myeloid|LAM / Condition, Lineage and Cell class | 1.03e-04 | 197 | 168 | 6 | 050911dcce17dee539bbaf79295e614ad84e1dae | |
| ToppCell | normal_Lung-Myeloid_cells-Alveolar_Mac|normal_Lung / Location, Cell class and cell subclass | 1.03e-04 | 197 | 168 | 6 | a158d8e697a122aa282f25a580179419644e749f | |
| ToppCell | normal_Lung-Myeloid_cells|normal_Lung / Location, Cell class and cell subclass | 1.03e-04 | 197 | 168 | 6 | 6407aa446a87a9c6fca723718acc19fd3afe06e8 | |
| ToppCell | 3'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-04 | 197 | 168 | 6 | 1614bc5f41fd2c8385e58ed6b87ef1536421f29a | |
| ToppCell | normal-na-Lymphocytic_NK-T_mait-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.03e-04 | 197 | 168 | 6 | 8752c0f37979aa7bf2e8aee6990fb6307a6666b7 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-04 | 197 | 168 | 6 | 1c78bd52b94a9466459a645ac9bd14bac22c54bd | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.03e-04 | 197 | 168 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.06e-04 | 198 | 168 | 6 | ab70bf89690410221ec7aa3149bb50ac34433f99 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 1.06e-04 | 198 | 168 | 6 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 198 | 168 | 6 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | C_01|World / shred on cell type and cluster | 1.06e-04 | 198 | 168 | 6 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 198 | 168 | 6 | 885cbd3695b466a161cf318d35ebbdfcc0c19cec | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 198 | 168 | 6 | 1771c282cd6422c35a4131c827d7daedfd6e7541 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 198 | 168 | 6 | 33690e16e4549b110e5b67f84b9515c696fe05e1 | |
| ToppCell | tumor_Lung-Myeloid_cells-mo-Mac|tumor_Lung / Location, Cell class and cell subclass | 1.09e-04 | 199 | 168 | 6 | 77d46acf655029eab23471dc4c4a1b0832b24306 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-04 | 199 | 168 | 6 | 54a54ad983503ed515d476882d86b17d97892037 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-04 | 199 | 168 | 6 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 199 | 168 | 6 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-04 | 199 | 168 | 6 | 8fcb32eee0ec0dd88209e723a6f82f425c73ca40 | |
| ToppCell | CF-Myeloid-Monocyte_Macrophage|CF / Disease state, Lineage and Cell class | 1.09e-04 | 199 | 168 | 6 | bf95eacb31a4a847350f9d6e95ca76c6b730c400 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-04 | 199 | 168 | 6 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-04 | 199 | 168 | 6 | 53dac0455b84597460457ed429969a42ed0fe932 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.12e-04 | 200 | 168 | 6 | bc56d6d6d32405685e9bd553ebdbe48b8fbe6902 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-04 | 200 | 168 | 6 | 5f41906cf1585e09b150a84364d47c3e466dc5b7 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.12e-04 | 200 | 168 | 6 | c87d6c59eb4e4118ef151f199b980221918444ae | |
| ToppCell | COVID-19|World / group, cell type (main and fine annotations) | 1.12e-04 | 200 | 168 | 6 | ac38a468559c33ee00152735ce6e408f3f48df84 | |
| ToppCell | control-MAIT|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.12e-04 | 200 | 168 | 6 | aeea4bda2e38cc6db571ed2b47ce022d637619bd | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-MAIT|IIF / Disease, condition lineage and cell class | 1.12e-04 | 200 | 168 | 6 | 7518bbf1c713b74f89be25ee700c6b0edc16ee8a | |
| ToppCell | Biopsy_Control_(H.)-Immune-Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.12e-04 | 200 | 168 | 6 | ad4c23e51bd34f5c515ce759a373ea431368a16e | |
| Computational | Genes in the cancer module 71. | 3.13e-05 | 22 | 91 | 4 | MODULE_71 | |
| Drug | lercanidipine | 7.91e-10 | 63 | 166 | 9 | CID000065866 | |
| Drug | gallopamil | 1.39e-09 | 67 | 166 | 9 | CID000001234 | |
| Drug | loperamide | CACNA1S ABCB5 RYR2 RYR3 ABCB1 CACNG3 CACNG2 CACNG8 CACNG7 CACNG4 | 5.14e-09 | 105 | 166 | 10 | CID000003954 |
| Drug | Cinildipine | 7.11e-09 | 56 | 166 | 8 | CID000002752 | |
| Drug | nilvadipine | 1.25e-08 | 60 | 166 | 8 | CID000004494 | |
| Drug | sulfinpyrazone | ABCB5 SLC22A11 ABCB1 ABCB4 SLC22A9 SLC16A3 SLC16A2 SLC16A14 SLC23A2 | 1.48e-08 | 87 | 166 | 9 | CID000005342 |
| Drug | probenecid | ABCB5 SLC22A11 ABCB1 ABCB4 SLC22A9 SLC16A5 SLC16A3 SLC16A2 SLC16A14 SLC23A2 | 2.39e-08 | 123 | 166 | 10 | CID000004911 |
| Drug | AC1L2AC7 | 3.86e-08 | 69 | 166 | 8 | CID000068733 | |
| Drug | nitrendipine | 4.23e-08 | 98 | 166 | 9 | CID000004507 | |
| Drug | CAS 298-57-7 | 6.06e-08 | 73 | 166 | 8 | CID000002761 | |
| Drug | ethosuximide | 6.75e-08 | 74 | 166 | 8 | CID000003291 | |
| Drug | nisoldipine | 1.02e-07 | 78 | 166 | 8 | CID000004499 | |
| Drug | nimodipine | CACNA1S ABCB5 RYR2 RYR3 ABCB1 CACNG3 CACNG2 CACNG8 CACNG7 CACNG4 | 1.14e-07 | 145 | 166 | 10 | CID000004497 |
| Drug | nicardipine | CACNA1S ABCB5 RYR2 RYR3 ABCB1 CACNG3 CACNG2 CACNG8 CACNG7 CACNG4 | 1.14e-07 | 145 | 166 | 10 | CID000004473 |
| Drug | CNS 1145 | 1.29e-07 | 33 | 166 | 6 | CID000190902 | |
| Drug | IHC-64 | 1.29e-07 | 33 | 166 | 6 | CID000162753 | |
| Drug | AC1MJ1SO | 1.29e-07 | 33 | 166 | 6 | CID003084042 | |
| Drug | Bay K 8644 | CACNA1S MGAM RYR2 RYR3 CACNG3 CACNG2 CACNG8 CACNG7 NF1 CACNG4 | 1.57e-07 | 150 | 166 | 10 | CID000002303 |
| Drug | lamotrigine | 1.83e-07 | 116 | 166 | 9 | CID000003878 | |
| Drug | dihydropyridine | CACNA1S ABCB5 RYR2 RYR3 ABCB1 CACNG3 CACNG2 CACNG8 CACNG7 COL14A1 CACNG4 | 1.84e-07 | 193 | 166 | 11 | CID000104822 |
| Drug | Zidovudine | SLC37A1 SLC39A9 SLC38A5 SLC2A3 ABCB1 PRDM1 SLC30A7 SLC38A2 SLC22A9 SLC16A4 SLC16A3 SLC12A9 SLC16A2 SLC28A1 SLC23A2 SLC29A1 ABCG8 | 2.87e-07 | 521 | 166 | 17 | ctd:D015215 |
| Drug | AC1NUZ8M | 3.73e-07 | 92 | 166 | 8 | CID000073211 | |
| Drug | pimozide | 3.98e-07 | 127 | 166 | 9 | CID000016362 | |
| Drug | mibefradil | 4.23e-07 | 64 | 166 | 7 | CID000060662 | |
| Drug | felodipine | CACNA1S ABCB5 RYR2 RYR3 ABCB1 CACNG3 CACNG2 CACNG8 CACNG7 CACNG4 | 4.77e-07 | 169 | 166 | 10 | CID000003333 |
| Drug | manidipine | 4.78e-07 | 95 | 166 | 8 | CID000004008 | |
| Drug | isotetrandrine | 5.62e-07 | 97 | 166 | 8 | CID000005422 | |
| Drug | verapamil | CACNA1S MGAM ABCB7 ABCB5 RYR2 RYR3 ABCB1 ABCB4 CACNG3 CACNG2 CACNG8 CACNG7 SLC25A40 KCNH1 CACNG4 ABCG8 | 6.47e-07 | 490 | 166 | 16 | CID000002520 |
| Drug | isradipine | 7.10e-07 | 100 | 166 | 8 | CID000003784 | |
| Drug | lanthanum | 7.11e-07 | 136 | 166 | 9 | CID000023926 | |
| Drug | cimetidine | ABCB5 SLC22A11 ABCB1 ABCB4 SLC22A9 SLC16A3 SLC16A2 SLC16A14 SLC9A7 SLC23A2 | 8.09e-07 | 179 | 166 | 10 | CID000002756 |
| Drug | NSC759576 | CACNA1S ABCB5 RYR2 RYR3 ABCB1 CACNG3 CACNG2 CACNG8 CACNG7 CACNG4 | 1.46e-06 | 191 | 166 | 10 | CID000003075 |
| Drug | Ursolic acid [77-52-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | CEP104 SLC39A9 SLC1A7 SVEP1 SLC35A3 CCDC88A NF1 COL14A1 CTNS SLC29A1 | 1.60e-06 | 193 | 166 | 10 | 7181_UP |
| Drug | NSC 117356 | ABCB5 SLC22A11 SLC44A4 ABCB1 ABCB4 SLC22A9 SLC16A3 SLC16A2 SLC16A14 MTR SLC23A2 | 2.03e-06 | 246 | 166 | 11 | CID000004112 |
| Drug | AC1NBU2S | 2.34e-06 | 117 | 166 | 8 | CID004473765 | |
| Drug | Pyruvic acid | 2.58e-06 | 14 | 166 | 4 | DB00119 | |
| Drug | FPL 64176 | 3.49e-06 | 15 | 166 | 4 | CID000003423 | |
| Drug | AC1L2MCS | 3.77e-06 | 5 | 166 | 3 | CID000023441 | |
| Drug | bepridil | 4.08e-06 | 126 | 166 | 8 | CID000002351 | |
| Drug | gabapentin | 4.32e-06 | 169 | 166 | 9 | CID000003446 | |
| Drug | NSC 284682 | 4.63e-06 | 16 | 166 | 4 | CID000072518 | |
| Drug | IAA-94 | 5.47e-06 | 61 | 166 | 6 | CID000003667 | |
| Drug | 6-methylpurine-2'-deoxyriboside | 5.47e-06 | 61 | 166 | 6 | CID000097184 | |
| Drug | sodium | CACNA1S MGAM SLC9A8 ATP6V0B SLC4A8 SLC38A5 SLC1A7 SLC2A3 RYR2 RYR3 SLC38A1 SLC38A2 SLC12A9 SLC16A2 P2RX2 KCNH1 SLC28A1 MTR SLC9A7 SLC23A2 SLC29A1 | 5.50e-06 | 944 | 166 | 21 | CID000000923 |
| Drug | Pgh1 | 6.02e-06 | 17 | 166 | 4 | CID005283048 | |
| Drug | cobalt-60 | CACNA1S MGAM SLC38A5 RYR2 RYR3 CACNG3 CACNG2 SLC30A7 CACNG8 CACNG7 POP1 MTR CACNG4 | 6.08e-06 | 390 | 166 | 13 | CID000061492 |
| Drug | chloro-m-cresol | 7.49e-06 | 6 | 166 | 3 | CID000012008 | |
| Drug | AC1L99H3 | 7.49e-06 | 6 | 166 | 3 | CID000440540 | |
| Drug | v 104 | 7.49e-06 | 6 | 166 | 3 | CID000107262 | |
| Drug | NSC114784 | 7.49e-06 | 6 | 166 | 3 | CID000419425 | |
| Drug | AC1L3X8G | 7.70e-06 | 18 | 166 | 4 | CID000123753 | |
| Drug | tetraethylammonium | SLC37A1 CACNA1S MGAM ABCB5 SLC22A11 ABCB1 SLC22A9 KCNH1 SLC22A2 MTR | 9.59e-06 | 236 | 166 | 10 | CID000005413 |
| Drug | sulfobromophthalein | 1.06e-05 | 103 | 166 | 7 | CID000005345 | |
| Drug | Dantrolene-13C3 | 1.15e-05 | 145 | 166 | 8 | CID000002951 | |
| Drug | pyraclofos | 1.28e-05 | 106 | 166 | 7 | CID000093460 | |
| Drug | C12-NBD-PC | 1.30e-05 | 7 | 166 | 3 | CID006439314 | |
| Drug | procaine | 1.70e-05 | 153 | 166 | 8 | CID000004914 | |
| Drug | tBCEU | 2.08e-05 | 8 | 166 | 3 | CID000164059 | |
| Drug | nicotine glucuronide | 2.08e-05 | 8 | 166 | 3 | CID003035848 | |
| Drug | iodoarylazidoprazosin | 2.08e-05 | 8 | 166 | 3 | CID000115344 | |
| Drug | tXMP | 2.08e-05 | 8 | 166 | 3 | CID003081384 | |
| Drug | o-CP | 2.28e-05 | 78 | 166 | 6 | CID000445454 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 2.46e-05 | 79 | 166 | 6 | CID005287890 | |
| Drug | So324 | 3.10e-05 | 9 | 166 | 3 | CID000462261 | |
| Drug | phenytoin | 3.43e-05 | 219 | 166 | 9 | CID000001775 | |
| Drug | AC1MZ4R5 | 4.40e-05 | 10 | 166 | 3 | CID003842392 | |
| Drug | AC1L2XOG | 4.40e-05 | 10 | 166 | 3 | CID000130599 | |
| Drug | Emd 51921 | 4.40e-05 | 10 | 166 | 3 | CID000164353 | |
| Drug | diC4PC | 4.40e-05 | 10 | 166 | 3 | CID000193375 | |
| Drug | azidopine | 4.87e-05 | 28 | 166 | 4 | CID000656406 | |
| Drug | mesochlorin e6 monoethylenediamine | 5.28e-05 | 2 | 166 | 2 | CID005488855 | |
| Drug | taxuspine C | 5.28e-05 | 2 | 166 | 2 | CID005321745 | |
| Drug | naphthyl sulfate | 5.28e-05 | 2 | 166 | 2 | ctd:C029092 | |
| Drug | 2,2-diphenyl-1,3-dioxolane | 5.28e-05 | 2 | 166 | 2 | CID000283230 | |
| Drug | Ro44-5912 | 5.28e-05 | 2 | 166 | 2 | CID000197370 | |
| Drug | cistinexine | 5.28e-05 | 2 | 166 | 2 | CID000065644 | |
| Drug | 8-(3,3-dimethylallyl)chrysin | 5.28e-05 | 2 | 166 | 2 | CID005281903 | |
| Drug | AC1L8LCS | 5.28e-05 | 2 | 166 | 2 | CID000383419 | |
| Drug | sulfurmycin A | 5.28e-05 | 2 | 166 | 2 | CID000155836 | |
| Drug | Procyclidine | 5.28e-05 | 2 | 166 | 2 | ctd:D011352 | |
| Drug | 1,9-dideoxyforskolin | 5.28e-05 | 2 | 166 | 2 | ctd:C047983 | |
| Drug | APCP | 5.28e-05 | 2 | 166 | 2 | CID003083759 | |
| Drug | DAPDOX | 5.28e-05 | 2 | 166 | 2 | CID000164413 | |
| Drug | AC1Q6JJG | 5.28e-05 | 2 | 166 | 2 | CID000164322 | |
| Drug | YM212 | 5.28e-05 | 2 | 166 | 2 | CID000129980 | |
| Drug | Ro11-2933 | 5.28e-05 | 2 | 166 | 2 | CID000115215 | |
| Drug | 4-methylumbelliferyl sulfate | 5.28e-05 | 2 | 166 | 2 | ctd:C019492 | |
| Drug | cnidiadin | 5.28e-05 | 2 | 166 | 2 | CID005315980 | |
| Drug | conferone | 5.28e-05 | 2 | 166 | 2 | CID001757335 | |
| Drug | VX-710-3 | 5.28e-05 | 2 | 166 | 2 | CID006450549 | |
| Drug | NAc-LLY-amide | 5.28e-05 | 2 | 166 | 2 | CID000443109 | |
| Drug | 62820-12-6 | 5.28e-05 | 2 | 166 | 2 | CID006449905 | |
| Drug | nifedipine | CACNA1S ABCB7 ABCB5 RYR2 RYR3 ABCB1 CACNG3 CACNG2 CACNG8 CACNG7 COL14A1 CACNG4 | 5.60e-05 | 415 | 166 | 12 | CID000004485 |
| Drug | AC1L9NBR | 5.83e-05 | 92 | 166 | 6 | CID000449625 | |
| Drug | dithiane | 6.02e-05 | 11 | 166 | 3 | CID000136335 | |
| Drug | AC1L9E0Q | 6.44e-05 | 30 | 166 | 4 | CID000443095 | |
| Drug | IC-1 | 7.98e-05 | 12 | 166 | 3 | CID000049829 | |
| Drug | isovalerate | 8.79e-05 | 143 | 166 | 7 | CID000010430 | |
| Drug | PF-01378883-00 [351320-41-7]; Up 200; 10uM; PC3; HT_HG-U133A | 9.20e-05 | 194 | 166 | 8 | 6368_UP | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 9.54e-05 | 195 | 166 | 8 | 2897_UP | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.36e-05 | 9 | 163 | 3 | DOID:1485 (implicated_via_orthology) | |
| Disease | age at menarche, spine bone mineral density | 1.93e-05 | 10 | 163 | 3 | EFO_0004703, EFO_0007701 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 6.93e-05 | 181 | 163 | 7 | DOID:684 (is_implicated_in) | |
| Disease | metabolite measurement | SLC24A5 RAPSN SLC22A24 SLC38A1 SLC38A2 SLC22A9 HOGA1 SLC22A2 MTNR1B SLC28A1 TBX20 ABCG8 | 7.04e-05 | 560 | 163 | 12 | EFO_0004725 |
| Disease | Intrahepatic cholestasis of pregnancy | 8.79e-05 | 16 | 163 | 3 | EFO_0009048 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 9.07e-05 | 3 | 163 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 9.07e-05 | 3 | 163 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 1.18e-04 | 197 | 163 | 7 | EFO_0005680 | |
| Disease | total lipids in small LDL | 1.33e-04 | 47 | 163 | 4 | EFO_0022168 | |
| Disease | free cholesterol in medium VLDL measurement | 1.33e-04 | 47 | 163 | 4 | EFO_0022269 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 2.28e-04 | 99 | 163 | 5 | EFO_0004611, EFO_0007878 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 2.62e-04 | 102 | 163 | 5 | EFO_0004329, EFO_0004611 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.96e-04 | 229 | 163 | 7 | EFO_0004639, EFO_0008317 | |
| Disease | nasal type extranodal NK/T-cell lymphoma (is_marker_for) | 3.00e-04 | 5 | 163 | 2 | DOID:0080797 (is_marker_for) | |
| Disease | epilepsy (implicated_via_orthology) | 3.01e-04 | 163 | 163 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | familial hyperlipidemia | 3.13e-04 | 106 | 163 | 5 | MONDO_0001336 | |
| Disease | Ulcerative Colitis | 4.15e-04 | 63 | 163 | 4 | C0009324 | |
| Disease | hydrocephalus (is_implicated_in) | 4.48e-04 | 6 | 163 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | 1,5 anhydroglucitol measurement | 5.44e-04 | 29 | 163 | 3 | EFO_0008009 | |
| Disease | Colorectal Carcinoma | ZDHHC2 ABCB5 APC ARID1A SLC44A4 SLC1A7 ABCB1 ABCB4 SLC22A9 NF1 TLR4 SLC29A1 | 5.55e-04 | 702 | 163 | 12 | C0009402 |
| Disease | cholesteryl ester measurement | 5.89e-04 | 257 | 163 | 7 | EFO_0010351 | |
| Disease | linoleic acid measurement | 6.06e-04 | 186 | 163 | 6 | EFO_0006807 | |
| Disease | cholesteryl ester 24:4 measurement | 6.25e-04 | 7 | 163 | 2 | EFO_0021447 | |
| Disease | very low density lipoprotein cholesterol measurement | 6.31e-04 | 260 | 163 | 7 | EFO_0008317 | |
| Disease | hair colour measurement | SLC24A5 TNIK ATG2A ARID1A SLC38A2 PLXDC2 SLC12A9 KCNH1 SBF2 TPRG1 SLC22A31 | 6.52e-04 | 615 | 163 | 11 | EFO_0007822 |
| Disease | Cholestasis of pregnancy | 8.31e-04 | 8 | 163 | 2 | C0268318 | |
| Disease | familial hyperlipidemia (is_implicated_in) | 8.31e-04 | 8 | 163 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | allergic rhinitis (is_implicated_in) | 8.31e-04 | 8 | 163 | 2 | DOID:4481 (is_implicated_in) | |
| Disease | triglyceride measurement, physical activity | 8.73e-04 | 34 | 163 | 3 | EFO_0003940, EFO_0004530 | |
| Disease | very low density lipoprotein particle size measurement | 8.80e-04 | 133 | 163 | 5 | EFO_0008594 | |
| Disease | metabolic syndrome | 8.85e-04 | 200 | 163 | 6 | EFO_0000195 | |
| Disease | gallbladder neoplasm | 1.06e-03 | 9 | 163 | 2 | EFO_0004606 | |
| Disease | familial Mediterranean fever (is_implicated_in) | 1.06e-03 | 9 | 163 | 2 | DOID:2987 (is_implicated_in) | |
| Disease | heart disease (implicated_via_orthology) | 1.21e-03 | 38 | 163 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.28e-03 | 215 | 163 | 6 | EFO_0008317, EFO_0008591 | |
| Disease | Liver Cirrhosis, Experimental | ZDHHC2 SLC25A24 DRAM1 INPP5D NBEA PTGER2 S1PR1 ABCB1 TLR4 C1QB ABCG8 IL7R | 1.29e-03 | 774 | 163 | 12 | C0023893 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.29e-03 | 145 | 163 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | estrogen measurement | 1.33e-03 | 10 | 163 | 2 | EFO_0011007 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [1] measurement | 1.33e-03 | 10 | 163 | 2 | EFO_0800507 | |
| Disease | cardiac troponin T measurement | 1.41e-03 | 219 | 163 | 6 | EFO_0005043 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.44e-03 | 220 | 163 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 1.61e-03 | 11 | 163 | 2 | EFO_0801461 | |
| Disease | chronic kidney disease, Proteinuria | 1.61e-03 | 11 | 163 | 2 | EFO_0003884, HP_0000093 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.64e-03 | 153 | 163 | 5 | EFO_0004611, EFO_0020946 | |
| Disease | concentration of large LDL particles measurement | 1.86e-03 | 44 | 163 | 3 | EFO_0022160 | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement | 1.93e-03 | 12 | 163 | 2 | EFO_0800500 | |
| Disease | phosphatidylcholine 34:4 measurement | 1.93e-03 | 12 | 163 | 2 | EFO_0010378 | |
| Disease | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) measurement | 1.93e-03 | 12 | 163 | 2 | EFO_0800453 | |
| Disease | Liver carcinoma | 2.11e-03 | 507 | 163 | 9 | C2239176 | |
| Disease | free cholesterol in small VLDL measurement | 2.25e-03 | 47 | 163 | 3 | EFO_0022272 | |
| Disease | triglyceride measurement, alcohol drinking | 2.25e-03 | 99 | 163 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | peak insulin response measurement | 2.27e-03 | 13 | 163 | 2 | EFO_0008000 | |
| Disease | total lipids in lipoprotein particles measurement | 2.39e-03 | 48 | 163 | 3 | EFO_0022309 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 2.42e-03 | 101 | 163 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | cholestasis (biomarker_via_orthology) | 2.53e-03 | 49 | 163 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | cholesterol in small LDL measurement | 2.53e-03 | 49 | 163 | 3 | EFO_0022227 | |
| Disease | Spastic Paraplegia, Hereditary | 2.64e-03 | 14 | 163 | 2 | C0037773 | |
| Disease | Adenocarcinoma Of Esophagus | 2.64e-03 | 14 | 163 | 2 | C0279628 | |
| Disease | body mass index, fasting blood glucose measurement | 2.84e-03 | 51 | 163 | 3 | EFO_0004340, EFO_0004465 | |
| Disease | phospholipids in medium VLDL measurement | 3.00e-03 | 52 | 163 | 3 | EFO_0022154 | |
| Disease | total lipids in medium LDL | 3.00e-03 | 52 | 163 | 3 | EFO_0022180 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] measurement | 3.04e-03 | 15 | 163 | 2 | EFO_0800508 | |
| Disease | glycerate measurement | 3.04e-03 | 15 | 163 | 2 | EFO_0021029 | |
| Disease | anemia (implicated_via_orthology) | 3.04e-03 | 15 | 163 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | gallstones | 3.08e-03 | 108 | 163 | 4 | EFO_0004210 | |
| Disease | cholesterol in small VLDL measurement | 3.17e-03 | 53 | 163 | 3 | EFO_0022228 | |
| Disease | total lipids in medium VLDL | 3.34e-03 | 54 | 163 | 3 | EFO_0022153 | |
| Disease | diastolic blood pressure, body mass index | 3.46e-03 | 16 | 163 | 2 | EFO_0004340, EFO_0006336 | |
| Disease | vitamin C measurement | 3.46e-03 | 16 | 163 | 2 | EFO_0600003 | |
| Disease | creatinine measurement | CACNA1S SLC52A1 RAPSN ARID1A TM6SF2 SLC44A4 SLC1A7 DDX1 PLXDC2 SLC22A2 CSPG4 PNPLA7 SLC23A2 | 3.64e-03 | 995 | 163 | 13 | EFO_0004518 |
| Disease | triglycerides in large VLDL measurement | 3.70e-03 | 56 | 163 | 3 | EFO_0022178 | |
| Disease | triglycerides in very large VLDL measurement | 3.70e-03 | 56 | 163 | 3 | EFO_0022325 | |
| Disease | antihyperlipidemic drug use measurement | 3.86e-03 | 115 | 163 | 4 | EFO_0803367 | |
| Disease | Huntington Disease | 3.91e-03 | 17 | 163 | 2 | C0020179 | |
| Disease | apolipoprotein B measurement | RAPSN WDR81 ARID1A TM6SF2 ABCB1 ABCB4 SLC38A1 NF1 SLC22A2 ABCG8 | 3.92e-03 | 663 | 163 | 10 | EFO_0004615 |
| Disease | triglycerides in VLDL measurement | 4.29e-03 | 59 | 163 | 3 | EFO_0022326 | |
| Disease | phospholipids in VLDL measurement | 4.29e-03 | 59 | 163 | 3 | EFO_0022301 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 4.38e-03 | 18 | 163 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.44e-03 | 276 | 163 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | phospholipids in small VLDL measurement | 4.50e-03 | 60 | 163 | 3 | EFO_0022146 | |
| Disease | Colorectal Neoplasms | 4.51e-03 | 277 | 163 | 6 | C0009404 | |
| Disease | amino acid measurement | SLC52A1 OR8U3 TMEM107 RYR2 RYR3 SLC38A1 OR4S1 COL14A1 OR4X1 MGAM2 | 4.58e-03 | 678 | 163 | 10 | EFO_0005134 |
| Disease | free cholesterol in VLDL measurement | 4.71e-03 | 61 | 163 | 3 | EFO_0022276 | |
| Disease | Cholecystitis | 4.88e-03 | 19 | 163 | 2 | HP_0001082 | |
| Disease | kidney failure (biomarker_via_orthology) | 4.88e-03 | 19 | 163 | 2 | DOID:1074 (biomarker_via_orthology) | |
| Disease | level of Sphingomyelin (d38:2) in blood serum | 4.88e-03 | 19 | 163 | 2 | OBA_2045179 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 4.88e-03 | 19 | 163 | 2 | OBA_2045199 | |
| Disease | diacylglycerol 38:5 measurement | 4.88e-03 | 19 | 163 | 2 | EFO_0020067 | |
| Disease | phospholipids in large VLDL measurement | 4.93e-03 | 62 | 163 | 3 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 4.93e-03 | 62 | 163 | 3 | EFO_0022322 | |
| Disease | total lipids in very large VLDL measurement | 4.93e-03 | 62 | 163 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 4.93e-03 | 62 | 163 | 3 | EFO_0022299 | |
| Disease | neuroimaging measurement, brain volume measurement | 5.26e-03 | 286 | 163 | 6 | EFO_0004346, EFO_0006930 | |
| Disease | iron biomarker measurement, transferrin measurement | 5.40e-03 | 20 | 163 | 2 | EFO_0004461, EFO_0006341 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 5.48e-03 | 127 | 163 | 4 | EFO_0008595, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GNSMQLARSSFGLFL | 6 | A6NC05 | |
| LMFTVGIDFTASNGN | 306 | Q96FN4 | |
| TMLARLASAASFFGE | 21 | Q6UVK1 | |
| SSVAGIFQLSMSDGA | 1911 | Q6UVK1 | |
| AMTSAVFAGGITLTN | 816 | Q96PE1 | |
| FQNMSTFSIGLAVGL | 186 | Q2M3G0 | |
| GMFTSVFFLSAIGLD | 111 | Q49SQ1 | |
| GAFAAFSLMTIAVGT | 16 | O60359 | |
| FLADGNVFTTGFSRM | 226 | Q9ULV4 | |
| FGHGSIQLSFMDTAA | 436 | Q9H221 | |
| SSLSFTVFDMSGQGR | 61 | Q9H0F7 | |
| ANSSFLTDGASAMLI | 306 | P55084 | |
| NTDLFFSMAGLTSSV | 361 | Q2TAZ0 | |
| QRGAASFGTSTAMAA | 1926 | Q96BY7 | |
| ANGVVSAGSSIFSMS | 231 | P36021 | |
| MSGSLAFGAVAEFSF | 381 | Q14498 | |
| SLSMGNAFLGLSVFQ | 126 | Q13702 | |
| GNRMTSTNLALVFGS | 371 | Q6ZRI8 | |
| QSSGFFGNLSMVTNL | 91 | P57740 | |
| VVFGAMAVGQVSSFA | 981 | P08183 | |
| SSSSSFAQQRFGAMG | 261 | O14497 | |
| GAFAAFSLMTIAVGT | 16 | Q9Y698 | |
| FGFMINFSAFLGAAT | 56 | Q8N682 | |
| LSFYNVSQMGALLAG | 456 | Q7RTW8 | |
| TFGTEMVSFVLAGFT | 191 | Q8N0Y5 | |
| LGCATQMAFFIALGS | 86 | Q8NGF6 | |
| VLTSQDCMAFGGNFL | 356 | Q6ZMT4 | |
| DFQVLAGSAGFLMAS | 216 | Q86XE5 | |
| QGFTGRFVFSMDTSA | 81 | A0A0B4J1V7 | |
| DARGSSFGVFLMNSN | 266 | Q2M2H8 | |
| SMFFNGLADLAGSTA | 301 | O15427 | |
| NDFLTKVLSGMAFAG | 401 | Q86WG5 | |
| VASSNSFMGTFGKAL | 1031 | Q6UXM1 | |
| FMSANTFGNAGFSVL | 281 | Q5U4P2 | |
| DASGLSFGVFLMNSN | 311 | O43451 | |
| DSGNGMSTFISALRN | 41 | A1A4Y4 | |
| SAFVMGLSVIGSVFN | 116 | P49286 | |
| TMQASLDLGTDKFGF | 151 | Q92499 | |
| ELGAMAFSTTAINFS | 1526 | Q3V6T2 | |
| SGGLMLFTAFVIQFT | 76 | Q63HM2 | |
| ASFGATVFAVLGFAM | 596 | Q8IXI2 | |
| MGLNKSASTFQLTGF | 1 | Q9H340 | |
| STNSSFLLTGFSGME | 16 | Q9H2C8 | |
| GFMVTANSGFISLAS | 196 | Q8NGB9 | |
| LGNLSFVDMTLASFA | 66 | Q8NGC6 | |
| IVVANSGMISLASFF | 196 | Q8NGB4 | |
| LTQMFSLHFFGGTEA | 96 | Q8NH49 | |
| GGSISVVSFFVLMAS | 201 | Q8NH49 | |
| AISSVMFSAGVLGNL | 26 | P43116 | |
| SSQMITFTFANGGVA | 541 | Q96G03 | |
| TFTFANGGVATMRTS | 546 | Q96G03 | |
| LLLFSNGMVQVSFSG | 266 | Q496M5 | |
| FTMTSLTSVGFGNIA | 456 | O95259 | |
| TMALSGISDFGNISA | 1011 | P32004 | |
| TTFGMVFSLLQVVSG | 6 | P16871 | |
| SMFSGAGFNSSIFSV | 1006 | Q6ZV29 | |
| LFFVLLGMSQAGSET | 16 | Q9Y5F1 | |
| MAQLGAVVAVASSFF | 1 | O94905 | |
| GNAMTVFFSILIGAF | 331 | P21439 | |
| ASAASFTPAMGSIFQ | 846 | A8CG34 | |
| RTLLGFVTQGDFSMA | 961 | Q99575 | |
| GASVSQFLGTMAPNF | 181 | Q9UBL9 | |
| SMAKGLVLGALFTSF | 11 | Q99999 | |
| TFGMLASGAFTALFG | 131 | P57057 | |
| QAGSDSLLTGMAFFK | 226 | Q9UIV1 | |
| QTMSSGFETLGSLFF | 766 | O43313 | |
| VGAFAAFGLMTIAIS | 26 | Q8WXS5 | |
| GSSGFTIDNVMKFSV | 601 | O60308 | |
| SVANRGQFASSGLSM | 491 | Q8WTW3 | |
| TSDGMNVLGIVFFSA | 216 | O00341 | |
| LLTTAGAFAAFSLMA | 11 | Q9UBN1 | |
| GAFAAFSLMAIAIGT | 16 | Q9UBN1 | |
| GLGTLAADANFIMAT | 1796 | Q13698 | |
| ASQASGFSDALTGMV | 901 | Q05707 | |
| ASSSFVLPFFGLGQM | 336 | Q6PD62 | |
| TISGDNIGKNFTFSM | 296 | Q8IZF7 | |
| SLLGMEGANSIFSGF | 231 | P02746 | |
| FAASSFLLKEGAGVM | 181 | P62955 | |
| GTNILSVMAAFAGTA | 141 | Q8N5U1 | |
| SVAIFSVGGMIGSFS | 66 | P11169 | |
| EGTTVLLFQFGMNAS | 281 | P11279 | |
| IASGFFSVFGMCVDT | 651 | Q53GD3 | |
| QAGSDSLLTGMAFFR | 226 | Q9UFF9 | |
| QSLGLSSAAASMFGK | 126 | O75208 | |
| SSLKMVQGGSFFSLQ | 181 | A6NC97 | |
| FTGGSFSLLQMFLQS | 306 | O60931 | |
| TLAAFLSLGMGFSRQ | 61 | Q5T1A1 | |
| SQALAFESSAGIFMG | 191 | P39059 | |
| FVAAFGMAGIFLSSL | 201 | Q9NSA0 | |
| AFSMGAGLFSVVGTL | 216 | A6NKX4 | |
| EGSMFVALSASVFSL | 121 | P21453 | |
| LFQSSVNVGFFIGSM | 151 | O15244 | |
| MTAAGAALVFVFSSG | 21 | Q8N1S5 | |
| NATGVAMLFSAGTFL | 241 | Q9NUM3 | |
| DVGFFQSLAGLMQSC | 3786 | Q92736 | |
| FFLGNLSVFDMGFSS | 61 | Q8NH80 | |
| AGAFAAGLLNFMVNT | 146 | O95221 | |
| FGLQGSAVASSFGNM | 486 | Q8TE04 | |
| ISLAGCGAQMFFFVT | 96 | Q8NGQ4 | |
| CGAQMFFFVTLGSTD | 101 | Q8NGQ4 | |
| TISFSGCAVQMFLGL | 91 | Q8NGT0 | |
| GSSLMVGSDVAFIAA | 206 | Q8NGK6 | |
| SFGMNIASATIALVG | 121 | Q96HJ5 | |
| LAFSQMVTTFGLAGI | 496 | Q13423 | |
| TSMGSLNVSVIFGFL | 206 | Q16563 | |
| GAVAAAAMTRTQGSF | 21 | Q7Z7N9 | |
| AGFSTMTILGNTFIL | 206 | Q8N4F4 | |
| MINFTSGALSGSFAA | 236 | Q8TBP6 | |
| GTASLFTNRMFVAFI | 306 | Q7RTX9 | |
| GKTSFGMSVFNLSNA | 46 | Q8WUX1 | |
| SGIAFMTLAGLAFAI | 241 | Q8IVM8 | |
| AMSSIASSQAFGNAL | 311 | P78424 | |
| TGMASGSIVAFNIDF | 2921 | Q8NFP9 | |
| GLSNLSFSFRGMEAI | 576 | Q99707 | |
| GSFTFQATLLMDGRI | 241 | Q6UX71 | |
| KGAVGVSFMFNGTSL | 521 | Q92835 | |
| VSFMFNGTSLGFVNS | 526 | Q92835 | |
| NMTDSFAFGSLISAV | 186 | Q9Y2E8 | |
| FGAFRSIMETLSGNQ | 861 | Q9Y6H5 | |
| GRSSMFVFFNGITNT | 521 | Q6ZUB0 | |
| SAVSSMNGINNFGLF | 426 | O75626 | |
| DTSGKSFGVFLMNSN | 286 | P14410 | |
| GASMTGIAYSLFAGQ | 516 | Q2Y0W8 | |
| AFAGFDMISSSSIVL | 201 | Q8NH85 | |
| GFLRFTETSMGSAVQ | 2726 | Q4LDE5 | |
| FGLTSALGQSFIFMT | 246 | P78383 | |
| FLAVLQEQFGSMAGS | 311 | Q9H6W3 | |
| TEKNSTSFFGLMAAA | 226 | Q9BSK2 | |
| IMSGQGLAGFFASVA | 176 | Q99808 | |
| TSTLAMLNFGQSAIF | 371 | O75027 | |
| MLNFGQSAIFSVGLT | 376 | O75027 | |
| NLTFSLASAEGFLMT | 696 | Q7Z7M1 | |
| FQQALGMFSAALASG | 336 | Q16186 | |
| AGMALTNLTFGDVAN | 501 | P25054 | |
| AQGSLFQGSMIGSFI | 171 | O95258 | |
| STLLNTMFGLRFATG | 706 | Q8TCY9 | |
| GRSSMFVFFNGITNT | 521 | P0C874 | |
| ANVALFSDGMLFTAT | 181 | Q9H3T3 | |
| FGTAATGFQQSSLNM | 681 | P98169 | |
| FASVRSGGSSQVFFM | 1336 | Q9UKE5 | |
| SGGSSQVFFMTLNRN | 1341 | Q9UKE5 | |
| SQFFSGAVLGSEMFV | 171 | Q8N966 | |
| NLNFMAIGFTDGSVT | 151 | Q9H270 | |
| VMAAIGLGFLTSSFR | 56 | Q02161 | |
| FLGLASFFAGMAVLS | 426 | O15374 | |
| SSFFLISAALFMGGS | 401 | O15375 | |
| SFGMCSSALVVFVFG | 116 | Q8NCC5 | |
| FCTLFGMITAVGLSN | 491 | Q9UGH3 | |
| SAHGAFLLGLMAFTS | 276 | Q9NWF4 | |
| FLLGLMAFTSAVTNG | 281 | Q9NWF4 | |
| DIFGFIGASAASMLI | 436 | Q96QD8 | |
| DAGFFQSLSGLMQSC | 3676 | Q15413 | |
| SFLAALAFSTMICAG | 396 | Q9BSA4 | |
| SMFGAGLTVGLSNLF | 136 | Q99437 | |
| TGAVMNFASVFAVLF | 261 | Q9BXP2 | |
| VVFTLGMFSAGLSDL | 16 | Q9BRV3 | |
| VELAGFLSGVSMFNS | 66 | Q6UX40 | |
| MSTIGSFEGFQAVSL | 1 | Q6ZUI0 | |
| FAGAIALSLVDMGSS | 226 | O75631 | |
| QDVAGTTFMAAGSSA | 106 | Q71RS6 | |
| SIGAVGSAMFLRFIN | 1401 | P21359 | |
| MAAAAAGTATSQRFF | 1 | Q9Y2Z0 | |
| MAAANLFAQTYGLTG | 766 | P22314 | |
| FSIDGSFAASVSIMG | 741 | Q9BZ71 | |
| FALCGFANFSSIGIM | 536 | O00337 | |
| MFFDSTAILAGLAAS | 71 | Q8NEW0 | |
| GSLQAFMDSFVLSSL | 916 | O15090 | |
| LMAVLTACFSSGFAG | 176 | Q9Y2D2 | |
| QGTGLAFIAFTEAMT | 436 | Q9H1V8 | |
| NAFSIAALMSSGGSK | 16 | Q9UMR3 | |
| FAAAMFSVSLSSLFG | 216 | Q9UIJ5 | |
| AATSGAVLQAATGMY | 81 | P48556 | |
| GSFAMSILVFLTGNI | 146 | Q9BZW4 | |
| FSGSFTMGAVTGVNA | 331 | Q96T83 | |
| MATAAGATYFQRGSL | 1 | Q8TBM7 | |
| LSFNGVITMSSNFLG | 406 | O00206 | |
| FGINAASLGSGMFNS | 366 | Q9NRR5 | |
| FMHFGAVLALSTLSG | 461 | Q6ZQQ6 | |
| FGATSLQNTGAMLSY | 151 | Q9H2H9 | |
| RFISGSMAGATAQTF | 291 | Q6NUK1 | |
| VVAGFSSGFMVLLDT | 1801 | Q562E7 | |
| LVVFMTVAAGGASSF | 16 | Q9C002 |